<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>Rasa Shastra &#8211; Ayurved Healing</title>
	<atom:link href="https://www.ayurvedhealing.com/tag/rasa-shastra/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.ayurvedhealing.com</link>
	<description>Ancient Wisdom for Modern Wellness</description>
	<lastBuildDate>Wed, 01 Jul 2026 02:11:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://img.ayurvedhealing.com/wp-content/uploads/2026/06/ayurvedhealing-lotus-favicon-150x150.png</url>
	<title>Rasa Shastra &#8211; Ayurved Healing</title>
	<link>https://www.ayurvedhealing.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Bhasma Particle Size Analysis: How Ayurvedic Metal Preparations Compare to Nanoparticles</title>
		<link>https://www.ayurvedhealing.com/bhasma-particle-size-analysis-metal-preparations-nanoparticles/</link>
					<comments>https://www.ayurvedhealing.com/bhasma-particle-size-analysis-metal-preparations-nanoparticles/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Mon, 24 Aug 2026 12:00:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Bhasma]]></category>
		<category><![CDATA[Metal Preparations]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Particle Size]]></category>
		<category><![CDATA[Rasa Shastra]]></category>
		<category><![CDATA[safety]]></category>
		<category><![CDATA[XRD Analysis]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=3530</guid>

					<description><![CDATA[Ancient Metal Processing Meets Modern Analytical Chemistry Rasa Shastra is the Ayurvedic pharmaceutical discipline that includes the processing and therapeutic use of metals, minerals, gems, and mineral-derived materials. It remains one of the most debated areas of Ayurveda because raw or poorly manufactured metal-containing products can be harmful, while the classical tradition requires elaborate purification, [&#8230;]]]></description>
										<content:encoded><![CDATA[<h2>Ancient Metal Processing Meets Modern Analytical Chemistry</h2>
<p>Rasa Shastra is the Ayurvedic pharmaceutical discipline that includes the processing and therapeutic use of metals, minerals, gems, and mineral-derived materials. It remains one of the most debated areas of Ayurveda because raw or poorly manufactured metal-containing products can be harmful, while the classical tradition requires elaborate purification, repeated incineration, and quality testing before internal use.</p>
<p>Modern analytical chemistry has added a clearer view of what happens during bhasma preparation. X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), field-emission TEM, energy-dispersive spectroscopy, inductively coupled plasma atomic emission spectroscopy, and related tools have been applied to selected bhasmas. The picture that emerges is more precise than the common claim that every bhasma is simply a “nanomedicine”: some preparations contain nanoscale particles, some contain submicron or micrometre-scale agglomerates made of smaller crystallites, and many show chemical phases that are distinctly different from the raw starting material.</p>
<p>This article reviews the analytical evidence in that balanced sense: bhasma preparation can create finely divided, chemically transformed mineral preparations, but the results are substance-specific, batch-specific, and dependent on the completeness of processing and testing.</p>
<h2>What Is a Bhasma? The Classical Process</h2>
<p>A bhasma is a calcined ash or calx prepared through repeated pharmaceutical processing. The steps vary by substance and textual tradition, but the core logic is consistent: remove impurities, alter the physical and chemical nature of the material, combine it with selected media through trituration, and subject it to controlled heating cycles until it passes classical quality tests.</p>
<ol>
<li><strong>Shodhana:</strong> The raw metal or mineral is purified through procedures such as heating, quenching, washing, levigation, or treatment with media such as sour gruel, buttermilk, cow urine, oil, herbal decoctions, lime water, or other substance-specific liquids.</li>
<li><strong>Jarana and allied processing:</strong> In some metallic preparations, an intermediate step is used to make the purified metal brittle, more reactive, and suitable for further incineration.</li>
<li><strong>Bhavana:</strong> The processed material is triturated with herbal juices, decoctions, or other prescribed liquids. This step can reduce particle size, improve mixing, and add organic residues or surface-associated constituents.</li>
<li><strong>Marana:</strong> The material is formed into small cakes or pellets, dried, sealed in earthen containers, and subjected to repeated puta or controlled heating cycles until the desired ash-like state is obtained.</li>
<li><strong>Bhasma pariksha:</strong> The finished material is examined through classical tests such as rekhapurnata, varitara, nishchandratva, apunarbhava, and niruttha to judge fineness, lightness, loss of metallic luster, irreversibility, and suitability for therapeutic use.</li>
</ol>
<p>The analytical question is not merely whether the particles become small, but whether the raw metal or mineral is transformed into a stable, reproducible, and pharmaceutically acceptable final material.</p>
<h2>What Analytical Studies Have Actually Found</h2>
<p>Different bhasmas do not all produce the same chemical form or particle-size range. Gold-based bhasmas may remain elemental gold at nanoscale dimensions, zinc and tin preparations may form oxides, iron preparations may form iron-oxide minerals, and mica-derived preparations may retain complex silicate and oxide phases. The following table summarizes verified analytical findings without assigning one universal particle size to all bhasmas.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Bhasma</th>
<th style="text-align:left;">Starting Material</th>
<th style="text-align:left;">Verified Analytical Finding</th>
<th style="text-align:left;">Reported Particle Scale</th>
<th style="text-align:left;">Important Interpretation</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swarna / Suvarna Bhasma</td>
<td>Gold</td>
<td>Crystalline elemental gold particles have been reported by XRD, TEM, FE-TEM, and related methods.</td>
<td>One older characterization reported globular particles around 56–57 nm; another FE-TEM analysis reported spherical gold nanoparticles around 5–20 nm.</td>
<td>Swarna Bhasma is not an oxide in these reports; it is better described as processed gold particles with nanoscale features in the analyzed samples.</td>
</tr>
<tr>
<td>Lauha Bhasma</td>
<td>Iron</td>
<td>Structural work describes conversion of metallic iron into iron-oxide mineral phases belonging to the magnetite group; other preparations have also been characterized as ferric oxide phases.</td>
<td>Reported as magnetite microparticles occurring as agglomerates of nanoparticles in one structural investigation.</td>
<td>The clinically relevant material is not raw iron filings; it is an iron-oxide preparation whose exact phase profile depends on processing.</td>
</tr>
<tr>
<td>Tamra Bhasma</td>
<td>Copper</td>
<td>Analytical reports describe copper oxide, especially cupric oxide (CuO), as a major phase in prepared Tamra Bhasma samples.</td>
<td>Microcrystalline and agglomerated morphology has been described; a single universal nanoscale value is not appropriate.</td>
<td>The preparation should not be equated with raw copper; however, copper-containing bhasmas require particularly strict quality control and dose discipline.</td>
</tr>
<tr>
<td>Yashada / Jasada Bhasma</td>
<td>Zinc</td>
<td>XRD has identified zinc oxide (ZnO) as the final phase in prepared Yashada Bhasma samples; intermediate stages can show incomplete transformation.</td>
<td>One study reported DLS particle size around 339.8 nm; another SEM-based study reported 5–20 µm particles.</td>
<td>Yashada Bhasma can be transformed into ZnO, but it should not be automatically described as 30–90 nm unless that exact batch has been tested.</td>
</tr>
<tr>
<td>Vanga Bhasma</td>
<td>Tin</td>
<td>Analytical work on Vanga Bhasma describes tin oxide formation and examines the effect of repeated calcination cycles on that transformation.</td>
<td>Particle size depends on method and batch; some later reports describe reduced or nanoscale particles, while oxide formation is the stronger verified finding.</td>
<td>The key transformation is from metallic tin toward tin oxide through repeated heating and processing.</td>
</tr>
<tr>
<td>Abhraka Bhasma</td>
<td>Mica / biotite</td>
<td>Abhraka-related analytical work describes complex silicate, oxide, and spinel-type phases with elements such as Si, Mg, O, Fe, Ca, Na, K, and Al.</td>
<td>One Krishna Vajra Abhraka Bhasma characterization reported nanoparticles with a mean SEM size around 92.3 nm; other mica-derived preparations show preparation-dependent mineral changes.</td>
<td>Mica-based bhasmas are mineral matrices rather than single-metal oxides, so their characterization must include both particle morphology and phase composition.</td>
</tr>
</tbody>
</table>
<p>The most reliable conclusion is that classical processing can substantially alter both particle structure and chemical form, but each bhasma requires its own analytical profile. A generic table assigning every bhasma to the same 20–100 nm range oversimplifies the actual literature.</p>
<h2>Chemical Transformation: More Than Particle Size</h2>
<p>Particle size is only one part of bhasma analysis. The chemical phase is equally important. XRD and related methods show that many metallic bhasmas are not simply powdered raw metals. Zinc preparations can become ZnO, tin preparations can become tin oxide, iron preparations can become magnetite or ferric oxide phases, and copper preparations can show copper oxide phases. Swarna Bhasma is a special case because verified analyses describe nanoscale elemental gold rather than a gold oxide.</p>
<p>This matters for safety and pharmacology because elemental metals, oxides, sulfides, silicate matrices, and nanoparticulate forms can behave very differently in the body. The classical tests of niruttha and apunarbhava address the same broad concern in traditional language: the finished bhasma should not behave like the original metal and should not easily return to a crude metallic state.</p>
<p>For Yashada Bhasma, a documented preparation showed incomplete transformation after an earlier heating stage, while the later prepared material was identified as ZnO and passed classical tests. That kind of stepwise transformation is exactly why both classical pariksha and modern instrumental testing are valuable.</p>
<h2>Classical Bhasma Tests as Practical Quality Screens</h2>
<p>The classical pariksha methods are practical bedside-style tests rather than substitutes for laboratory analysis. Rekhapurnata checks whether the powder is fine enough to enter the lines of the fingers. Varitara checks whether the powder can float on still water. Nishchandratva checks absence of metallic shine. Apunarbhava and niruttha examine whether the material remains stable and does not return to a crude metallic form under specified procedures.</p>
<p>These tests are meaningful because they assess fineness, lightness, lusterlessness, and irreversible processing. However, passing varitara alone does not prove that every particle is within the 1–100 nm nanotechnology range. Floating behavior can be influenced by particle size, aggregation, surface texture, wetting behavior, and bulk density. The strongest approach is to treat classical tests as necessary screening tools and pair them with XRD, SEM/TEM, ICP-MS or ICP-AES, and batch-level contaminant analysis.</p>
<h2>Why Nanostructure Matters Biologically</h2>
<p>In nanomedicine, particle size, surface charge, solubility, coating, aggregation, and protein binding influence absorption, cellular interaction, biodistribution, and clearance. Particles in the nanoscale or submicron range may interact with intestinal epithelial cells, mucus, immune cells, and M cells differently from coarse powders. This gives a plausible scientific reason to examine bhasmas with modern nanomaterial tools.</p>
<p>That does not mean a nanoscale bhasma automatically has predictable clinical effects. A 20 nm gold particle, a 300 nm ZnO particle, and a micrometre-scale agglomerate of iron-oxide nanocrystallites are different materials. Their behavior depends not only on size but also on dose, route of administration, solubility in gastric and intestinal fluids, surface chemistry, accompanying anupana, and the patient’s condition.</p>
<p>For Swarna Bhasma, in vitro and animal-level work provides a basis for continued investigation of gold-particle preparations. For Lauha, Yashada, Vanga, Tamra, and Abhraka preparations, the analytical value lies in showing how classical processing changes the material, not in assuming that all such products behave identically.</p>
<h2>Safety Considerations: Where Caution Is Warranted</h2>
<p>The analytical finding that some bhasmas are finely divided or nanoscale is a double-edged observation. It may help explain why classical processing was developed so carefully, but it also raises modern safety concerns. Finely divided particles can have higher surface area, different reactivity, and different tissue interactions than bulk materials. Metal-containing preparations therefore require careful sourcing, testing, dosing, and clinical supervision.</p>
<p>Reports of heavy-metal exposure from Ayurvedic products are real and should not be dismissed. Surveys of Ayurvedic medicines purchased in stores or online have found lead, mercury, or arsenic in a significant minority of products, and public-health reports have documented lead poisoning associated with Ayurvedic medications. These findings do not prove that every classically prepared bhasma is unsafe, but they do prove that product quality and supervision are essential.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Safety Factor</th>
<th style="text-align:left;">Classical Safeguard</th>
<th style="text-align:left;">Modern Quality-Control Counterpart</th>
<th style="text-align:left;">Practical Concern</th>
</tr>
</thead>
<tbody>
<tr>
<td>Identity of raw material</td>
<td>Correct selection and shodhana of the metal or mineral</td>
<td>Authentication, elemental analysis, and impurity profiling</td>
<td>Wrong raw material or contaminated raw material can compromise the entire product.</td>
</tr>
<tr>
<td>Chemical transformation</td>
<td>Marana, apunarbhava, and niruttha</td>
<td>XRD, FTIR, XPS, Raman spectroscopy, and phase analysis</td>
<td>Incomplete calcination can leave unwanted metallic or intermediate phases.</td>
</tr>
<tr>
<td>Particle fineness</td>
<td>Rekhapurnata and varitara</td>
<td>SEM, TEM, DLS, particle-size distribution, and surface-area testing</td>
<td>Fine particles may improve dispersion but also require careful toxicological assessment.</td>
</tr>
<tr>
<td>Heavy-metal exposure</td>
<td>Correct purification, incineration, dose, and anupana</td>
<td>ICP-MS, ICP-AES, AAS, and batch-specific contaminant limits</td>
<td>Finished products should be tested for toxic elements and not assumed safe from name alone.</td>
</tr>
<tr>
<td>Clinical use</td>
<td>Small dose, correct indication, appropriate duration, and physician supervision</td>
<td>Prescription review, liver and kidney function monitoring, and adverse-event tracking</td>
<td>Self-medication, prolonged unsupervised use, pregnancy, childhood use, kidney disease, liver disease, and polypharmacy increase risk.</td>
</tr>
</tbody>
</table>
<h2>Comparing Bhasmas to Modern Nanoformulations</h2>
<p>There are meaningful parallels between some bhasmas and modern nanomaterials, but they should not be treated as identical. Zinc oxide is widely used in modern topical products such as sunscreens, and zinc oxide nanoparticles are studied for wound-related biomedical applications. Iron oxide nanoparticles, including ferumoxytol, are used in modern medicine as regulated injectable products. Gold nanoparticles are widely investigated as drug carriers, imaging agents, and cancer-therapy adjuncts.</p>
<p>The similarity is that particle size and surface properties matter in both traditional bhasma analysis and modern nanomedicine. The difference is that approved nanomedicines are manufactured under defined pharmaceutical standards, with controlled route of administration, dose, sterility, pharmacokinetics, warnings, and formal regulatory documentation. Bhasmas vary by raw material, processing method, number of heating cycles, media used for bhavana, manufacturer, and testing discipline.</p>
<p>For context on how other traditional preparations interact with biological systems at the molecular level, <a href="/cox-2-inhibition-explained-how-turmeric-boswellia-and-ginger-fight-inflammation/">COX-2 Inhibition Explained</a> examines how plant-derived compounds affect specific enzymatic pathways.</p>
<h2>Practical Implications</h2>
<p>For clinicians and patients, the practical message is neither blind rejection nor casual acceptance. Bhasmas are potent metal- or mineral-derived preparations that require the same seriousness as any other high-risk pharmaceutical material.</p>
<ol>
<li><strong>Use only tested products:</strong> A bhasma should come from a manufacturer able to document raw-material identity, classical processing, finished-product testing, and contaminant limits.</li>
<li><strong>Ask for batch-level analysis:</strong> XRD or equivalent phase analysis, particle characterization, and heavy-metal contaminant testing are more meaningful than generic marketing language.</li>
<li><strong>Respect classical dose and duration:</strong> Traditional bhasma doses are small and indication-specific. More is not better, and long-term use should not be casual.</li>
<li><strong>Avoid self-prescription:</strong> Bhasmas should be used only under a qualified Ayurvedic physician trained in Rasa Shastra and aware of the patient’s medical history.</li>
<li><strong>Coordinate with modern care:</strong> Patients should inform their healthcare provider about bhasma use, especially if taking medicines, managing kidney or liver disease, pregnant, breastfeeding, elderly, or using the preparation for a child.</li>
<li><strong>Monitor when therapy is extended:</strong> Periodic liver function, kidney function, blood counts, and relevant toxic-metal testing may be prudent when bhasmas are used beyond a short course.</li>
</ol>
<p>For those interested in the broader relationship between Ayurvedic formulation science and modern pharmacology, <a href="/science-anupana-carrier-substances-herb-pharmacokinetics/">The Science of Anupana</a> explores how carrier substances modify absorption and distribution.</p>
<h2>Where the Evidence Stands</h2>
<p>Bhasma analysis is one of the more useful meeting points between Ayurveda and modern pharmaceutical chemistry. It allows traditional preparations to be examined as materials: What phase is present? How large are the particles? Are they agglomerated? What elements are present? Is the raw metal transformed? Does the product pass both classical and instrumental quality checks?</p>
<p>The available analytical picture supports a qualified conclusion. Properly processed bhasmas can be chemically and physically distinct from their raw starting materials, and some contain nanoscale or nanostructured features. At the same time, the findings are not uniform across all bhasmas or all manufacturers. A gold bhasma, a zinc oxide bhasma, a tin oxide bhasma, an iron oxide bhasma, and a mica-derived bhasma are different materials and should be evaluated separately.</p>
<p>The most responsible position is continued scientific interest with strict quality control and clinical caution. Classical processing deserves careful study, but safety and efficacy must be judged preparation by preparation, batch by batch, and patient by patient.</p>
<div style="background-color:#fff3cd; border:1px solid #ffc107; padding:15px; margin:20px 0; border-radius:5px;"> <strong>Medical Disclaimer:</strong> This article is for educational purposes only and does not constitute medical advice. Bhasma preparations contain metals or minerals and can be toxic if improperly prepared, contaminated, incorrectly prescribed, or used in excessive doses. Never self-prescribe bhasma preparations. Use them only under the guidance of a qualified Ayurvedic physician with training in Rasa Shastra, and inform your conventional healthcare provider about any bhasma or herbo-mineral preparation you take. </div>
<p><em>Nothing in this article diagnoses, treats, cures, or prevents disease. Consult a qualified Ayurvedic practitioner and a licensed healthcare provider before starting herbs, minerals, supplements, detoxes, or therapeutic protocols, especially if pregnant, breastfeeding, giving to a child, managing a medical condition, or taking medication.</em></p>
<h2>References</h2>
<ol>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3960793/" rel="nofollow noopener noreferrer" target="_blank">Bhasma : The ancient Indian nanomedicine (2014), PubMed Central</a></li>
<li><a href="https://www.omicsonline.org/scientific-reports/2167-1206-SR-582.pdf" rel="nofollow noopener noreferrer" target="_blank">Omicsonline (omicsonline.org)</a></li>
<li><a href="https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/considerations-drug-products-contain-nanomaterials" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://link.springer.com/article/10.1007/BF03215588" rel="nofollow noopener noreferrer" target="_blank">Link (link.springer.com)</a></li>
<li><a href="https://progenresearchlab.com/wp-content/uploads/2026/05/Swarnabhasma-nano.pdf" rel="nofollow noopener noreferrer" target="_blank">Progenresearchlab (progenresearchlab.com)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/34690042/" rel="nofollow noopener noreferrer" target="_blank">Nanostructured gold in ancient Ayurvedic calcined drug &#8216;swarnabhasma&#8217; (2021), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3157103/" rel="nofollow noopener noreferrer" target="_blank">Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/31730889/" rel="nofollow noopener noreferrer" target="_blank">Physicochemical characterization of Suvarna Bhasma, its toxicity profiling in rat and behavioural assessment in zebrafish model (2020), PubMed</a></li>
<li><a href="https://arxiv.org/abs/2207.14615" rel="nofollow noopener noreferrer" target="_blank">Arxiv (arxiv.org)</a></li>
<li><a href="https://www.ijpsonline.com/articles/pharmaceutical-standardization-of-traditionally-prepared-emlauha-bhasmaem-incinerated-iron-characterised-as-alpha-haematite-5313.html" rel="nofollow noopener noreferrer" target="_blank">Ijpsonline (ijpsonline.com)</a></li>
<li><a href="https://www.ijam.co.in/index.php/ijam/article/view/2577/909" rel="nofollow noopener noreferrer" target="_blank">Ijam (ijam.co.in)</a></li>
<li><a href="https://library.ncl.res.in/content/preparation-and-characterization-copper-based-indian-traditional-drug-tamra-bhasma-0" rel="nofollow noopener noreferrer" target="_blank">Library (library.ncl.res.in)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/16095857/" rel="nofollow noopener noreferrer" target="_blank">Preparation and characterization of a copper based Indian traditional drug: tamra bhasma (2005), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/30962052/" rel="nofollow noopener noreferrer" target="_blank">Physico-chemical characterization of traditionally prepared Yashada bhasma (2020), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/16682160/" rel="nofollow noopener noreferrer" target="_blank">Effect of calcination cycles on the preparation of tin oxide based traditional drug: studies on its formation and characterization (2006), PubMed</a></li>
<li><a href="https://www.ijam.co.in/index.php/ijam/article/view/05152014" rel="nofollow noopener noreferrer" target="_blank">Ijam (ijam.co.in)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8185977/" rel="nofollow noopener noreferrer" target="_blank">Nanoparticles of biotite mica as KrishnaVajraAbhraka Bhasma: synthesis and characterization (2021), PubMed Central</a></li>
<li><a href="https://library.ncl.res.in/content/nanoparticles-biotite-mica-krishna-vajra-abhraka-bhasma-synthesis-and-characterization" rel="nofollow noopener noreferrer" target="_blank">Library (library.ncl.res.in)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7393536/" rel="nofollow noopener noreferrer" target="_blank">Characterization of biotite drugs used in traditional medicine (2020), PubMed Central</a></li>
<li><a href="https://www.fda.gov/drugs/understanding-over-counter-medicines/questions-and-answers-fda-posts-deemed-final-order-and-proposed-order-over-counter-sunscreen" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8692919/" rel="nofollow noopener noreferrer" target="_blank">Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle (2022), PubMed Central</a></li>
<li><a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022180lbl.pdf" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3473940/" rel="nofollow noopener noreferrer" target="_blank">Gold nanoparticles as novel agents for cancer therapy (2012), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5561790/" rel="nofollow noopener noreferrer" target="_blank">The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction (2016), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11531169/" rel="nofollow noopener noreferrer" target="_blank">Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties (2024), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/15598918/" rel="nofollow noopener noreferrer" target="_blank">Heavy metal content of ayurvedic herbal medicine products (2004), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/18728265/" rel="nofollow noopener noreferrer" target="_blank">Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed</a></li>
<li><a href="https://jamanetwork.com/journals/jama/fullarticle/182460" rel="nofollow noopener noreferrer" target="_blank">Jamanetwork (jamanetwork.com)</a></li>
<li><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5326a3.htm" rel="nofollow noopener noreferrer" target="_blank">CDC</a></li>
<li><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6133a1.htm" rel="nofollow noopener noreferrer" target="_blank">CDC</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2996572/" rel="nofollow noopener noreferrer" target="_blank">Mahayograj guggulu: Heavy metal estimation and safety studies (2010), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/24250122/" rel="nofollow noopener noreferrer" target="_blank">Clinical trial on different dose patterns of Shodhanartha Abhyantara Snehana (2013), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/25364201/" rel="nofollow noopener noreferrer" target="_blank">Phytochemical and analytical evaluation of Jyotishmati (Celastrus paniculatus Willd.) leaf extracts (2014), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/26604550/" rel="nofollow noopener noreferrer" target="_blank">Anxiolytic and nootropic activity of Vetiveria zizanioides roots in mice (2015), PubMed</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/bhasma-particle-size-analysis-metal-preparations-nanoparticles/feed/</wfw:commentRss>
			<slash:comments>57</slash:comments>
		
		
			</item>
		<item>
		<title>Heavy Metal Content in Bhasma Preparations: Safety Data from ICP-MS Analytical Studies</title>
		<link>https://www.ayurvedhealing.com/heavy-metal-content-bhasma-preparations-icp-ms-safety-data/</link>
					<comments>https://www.ayurvedhealing.com/heavy-metal-content-bhasma-preparations-icp-ms-safety-data/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Sat, 01 Aug 2026 06:00:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Analytical Chemistry]]></category>
		<category><![CDATA[Bhasma]]></category>
		<category><![CDATA[Heavy Metals]]></category>
		<category><![CDATA[ICP-MS]]></category>
		<category><![CDATA[Metal Toxicity]]></category>
		<category><![CDATA[Quality Control]]></category>
		<category><![CDATA[Rasa Shastra]]></category>
		<category><![CDATA[Safety Testing]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=3411</guid>

					<description><![CDATA[Heavy Metal Content in Bhasma Preparations: Safety Data from Modern Analytical Studies Few topics in Ayurvedic medicine generate as much controversy as bhasma preparations. These calcined metal, mineral, and animal-origin preparations belong to the Rasa Shastra tradition and have a long clinical history, yet they also sit at the center of legitimate safety concerns about [&#8230;]]]></description>
										<content:encoded><![CDATA[<h1>Heavy Metal Content in Bhasma Preparations: Safety Data from Modern Analytical Studies</h1>
<p>Few topics in Ayurvedic medicine generate as much controversy as bhasma preparations. These calcined metal, mineral, and animal-origin preparations belong to the Rasa Shastra tradition and have a long clinical history, yet they also sit at the center of legitimate safety concerns about lead, mercury, arsenic, and other toxic elements in Ayurvedic products.</p>
<p>A careful reading is more useful than either blanket fear or blanket reassurance. Properly manufactured bhasma is not the same as accidental heavy-metal contamination in an herbal capsule, because its intended material, processing, particle size, and chemical form all matter. At the same time, laboratory testing has repeatedly found unsafe metals in some commercial Ayurvedic products, especially products bought from unverified sources. Safety depends on identity, classical processing, chemical speciation, batch testing, dose, duration, and medical supervision.</p>
<h2>What Are Bhasma Preparations?</h2>
<p>Bhasma means an ash-like calcined product. In Rasa Shastra pharmaceutics, a metal, mineral, shell, pearl, coral, or related material is processed through purification and incineration stages known broadly as <em>shodhana</em> and <em>marana</em>. The material may be triturated with herbal juices or decoctions, made into pellets, sealed in earthen containers, and repeatedly heated. The intended result is a fine, lusterless, stable preparation rather than crude metal powder.</p>
<p>Classical and pharmaceutic quality checks are used to judge whether incineration has reached the expected endpoint. Modern laboratories add elemental analysis and structural analysis to these traditional tests, because the same named bhasma can vary by raw material, heating method, number of calcination cycles, and manufacturer.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Classical Test</th>
<th style="text-align:left;">Sanskrit Name</th>
<th style="text-align:left;">Practical Meaning</th>
<th style="text-align:left;">Modern Quality Concern Addressed</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lusterlessness</td>
<td><em>Nishchandratva</em></td>
<td>No visible metallic shine remains.</td>
<td>Helps screen for unprocessed free metal particles.</td>
</tr>
<tr>
<td>Fineness</td>
<td><em>Rekhapurnatva</em></td>
<td>The powder enters fine lines of the fingers when rubbed.</td>
<td>Indicates high fineness and reduction of coarse particles.</td>
</tr>
<tr>
<td>Floatability</td>
<td><em>Varitaratva</em></td>
<td>A small quantity floats on still water.</td>
<td>Reflects lightness and fine powder behavior.</td>
</tr>
<tr>
<td>Irreversibility</td>
<td><em>Apunarbhavatva</em></td>
<td>The material should not revert to its original metallic state after further heating with specified media.</td>
<td>Addresses incomplete conversion of the starting metal.</td>
</tr>
<tr>
<td>Non-reducibility</td>
<td><em>Niruttha</em></td>
<td>The product should not transfer metal to silver in the classical test.</td>
<td>Another screen for residual free metal.</td>
</tr>
<tr>
<td>Tastelessness</td>
<td><em>Niswadutva</em></td>
<td>The product should not have a sharp metallic taste.</td>
<td>Helps identify incomplete processing in some preparations.</td>
</tr>
</tbody>
</table>
<h2>What Modern Analysis Adds</h2>
<p>Modern testing separates several questions that are often mixed together: how much of an element is present, what chemical compound it is present as, what particle size and morphology it has, whether toxic impurities are present, and how much enters systemic circulation. ICP-MS, ICP-OES, ICP-AES, X-ray fluorescence, X-ray diffraction, scanning electron microscopy, transmission electron microscopy, and related methods each answer different parts of that safety question.</p>
<p>Total metal content alone is not enough to judge a genuine metal-based bhasma, because a gold, iron, copper, zinc, tin, lead, or mercury preparation will naturally contain the intended element. For safety, total elemental analysis must be read together with chemical form, solubility, particle size, dose, duration, patient factors, and batch purity. For herbal-only products, however, lead, mercury, arsenic, and cadmium are contaminants unless clearly declared and justified by the formulation.</p>
<h2>Swarna Bhasma: Gold Content, Particle Form, and Absorption</h2>
<p>Swarna Bhasma is one of the most discussed bhasma preparations because gold is a noble metal and the prescribed doses are small. Published characterization work has reported gold as the major phase in prepared samples, but the percentage and particle dimensions vary across preparations and methods.</p>
<p>In one pharmaceutical standardization study, Swarna Bhasma prepared through a traditional method passed selected bhasma tests such as <em>varitaratva</em>, <em>rekhapurnatva</em>, and expected color. The finished product contained 52.33% gold by ICP-OES, with lead and cadmium below detection limits in that batch, while arsenic and mercury were detected. The same report also recorded particle sizes in the 1–10 µm range by spot magnification, showing that not every finished product can be described simply as a uniform nanoparticle preparation.</p>
<p>A human pilot bioavailability assessment administered Swarnabhasma in three regimens and measured blood gold using ICP-MS. Gold was detected only in trace amounts after a single dose. This supports cautious dosing and supervision rather than casual long-term self-use, because trace absorption does not remove the need for product identity and contaminant testing.</p>
<h2>Tamra Bhasma: Copper Form Is Central to Safety</h2>
<p>Tamra Bhasma requires special caution because copper in inappropriate form or excessive dose can cause gastrointestinal and systemic toxicity. The Ayurvedic safety logic is that copper must be purified, repeatedly processed, and converted into a stable bhasma that passes classical endpoint tests.</p>
<p>A quality-control study of Tamra Bhasma prepared from copper wire applied <em>shodhana</em>, <em>marana</em>, and <em>amritikarana</em>, then evaluated the final product using classical tests and modern tools. The final product passed tests such as <em>rekhapurnatva</em> and <em>varitaratva</em>. XRD showed prominent peaks of cupric sulfide, SEM showed particles below 2 µm, particle-size distribution gave a volumetric mean diameter of 28.70 µm, and ICP-AES measured 56.42% copper with 23.06% sulfur. Arsenic, lead, and mercury were present only in traces in that sample, while cadmium and selenium were not detected.</p>
<p>These details are important because they correct an oversimplified claim often made in discussions of Tamra Bhasma: a named bhasma cannot be assumed to be only one oxide form, nor can safety be inferred from name alone. The batch must be tested.</p>
<h2>Lauha Bhasma and Yashada Bhasma: Iron and Zinc Preparations</h2>
<p>Lauha Bhasma and Yashada Bhasma are often discussed as lower-concern metal bhasma when properly manufactured, because iron and zinc are essential elements. That does not mean they are risk-free. Excess iron can accumulate in susceptible patients, and zinc preparations can vary in chemical form and impurities.</p>
<p>Work on Lauha Bhasma preparation has described the importance of sequential purification and calcination in changing raw iron into a more processed iron-based material. Structural investigation of medicinal-grade Lauha Bhasma reported conversion of metallic iron into iron-oxide mineral phases, with magnetite microparticles appearing as agglomerates of nanoparticles. Yashada Bhasma analyses have reported zinc oxide or zinc sulfide phases depending on the processing method, with ICP-based elemental profiling used to assess trace elements and heavy metals.</p>
<h2>The JAMA Internet-Product Survey: What It Really Means</h2>
<p>The widely cited JAMA survey of Ayurvedic medicines sold via the internet remains highly relevant for public safety. It purchased 230 products, received and analyzed 193, and found detectable lead, mercury, or arsenic in 20.7% of products. Rasa Shastra products had a higher prevalence of detectable metals than non-Rasa Shastra products, and all metal-containing products exceeded at least one standard for acceptable daily intake of toxic metals.</p>
<p>The survey should be read as a serious product-quality warning. It tested commercial products bought online, not carefully supervised individualized prescribing from a qualified practitioner. It also measured metal concentrations rather than clinical pharmacokinetics or chemical speciation. Still, its practical message is unavoidable: consumers cannot assume an Ayurvedic label, an online listing, or a stated GMP claim guarantees safety.</p>
<h2>Total Metal, Chemical Form, and Bioavailability</h2>
<p>Total metal content answers only one part of the safety question. Iron oxide, elemental iron, soluble iron salts, and iron bound in hemoglobin all contain iron but behave differently in the body. The same principle applies to copper, zinc, mercury, lead, and arsenic: chemical form and solubility matter.</p>
<p>Mercury illustrates the point clearly. Cinnabar and mercuric sulfide are poorly absorbed from the gastrointestinal tract compared with methylmercury and more soluble mercury salts. This distinction is chemically meaningful, but it is not a license for self-medication with mercury-containing preparations. Poor absorption does not mean zero absorption, and cumulative exposure, impurities, overheating, wrong processing, wrong dose, and vulnerable patients can still create risk.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th style="text-align:left;">Preparation Type</th>
<th style="text-align:left;">Key Analytical Point</th>
<th style="text-align:left;">Safety Interpretation</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swarna Bhasma</td>
<td>Gold may be the major phase, but gold percentage, particle size, and trace elements differ by batch and method.</td>
<td>Requires identity testing and contaminant testing despite generally low systemic gold absorption in a small pilot study.</td>
</tr>
<tr>
<td>Tamra Bhasma</td>
<td>Published samples include sulfide forms and measurable trace contaminants.</td>
<td>Requires strict processing, low dose, short duration, and practitioner monitoring.</td>
</tr>
<tr>
<td>Lauha Bhasma</td>
<td>Processing changes raw iron into iron-oxide phases.</td>
<td>May be appropriate only when iron therapy is indicated; avoid unsupervised long-term use and consider ferritin status.</td>
</tr>
<tr>
<td>Yashada Bhasma</td>
<td>Different procedures may yield zinc oxide or zinc sulfide phases with different trace-element profiles.</td>
<td>Requires batch testing and avoidance of unnecessary zinc exposure.</td>
</tr>
<tr>
<td>Naga Bhasma</td>
<td>Lead-based preparations can contain lead sulfide or other lead compounds depending on processing.</td>
<td>High-risk category; specialist-only use, strong justification, and modern monitoring are essential.</td>
</tr>
<tr>
<td>Mercury-containing preparations</td>
<td>Mercury sulfide is less absorbable than methylmercury, but exposure is not zero.</td>
<td>High-risk category; avoid self-use and restrict to expert supervision where legally and clinically appropriate.</td>
</tr>
</tbody>
</table>
<h2>Which Bhasma Carry Lower or Higher Concern?</h2>
<p>A practical safety ranking should not claim that any bhasma is automatically safe. It should separate lower-concern mineral preparations from preparations that contain toxic metals or require especially narrow dosing discipline.</p>
<h3>Lower Concern When Properly Manufactured</h3>
<p>Some preparations are based mainly on calcium carbonate, silicate minerals, iron, or zinc. Their risk is usually driven by product purity, inappropriate indication, wrong dose, prolonged use, and patient susceptibility rather than by the inherent toxicity of lead or mercury.</p>
<ul>
<li><strong>Shankha Bhasma:</strong> A conch-shell preparation, mainly calcium-rich, traditionally used for acid-peptic and digestive indications.</li>
<li><strong>Praval and Mukta preparations:</strong> Coral and pearl preparations are calcium-carbonate based but still require authenticity and contaminant checks.</li>
<li><strong>Abhraka Bhasma:</strong> A mica-based silicate preparation requiring careful processing and batch standardization.</li>
<li><strong>Lauha Bhasma:</strong> Iron-based; avoid unnecessary use in people with high ferritin, iron overload disorders, active infection concerns, or liver disease unless supervised.</li>
<li><strong>Yashada Bhasma:</strong> Zinc-based; avoid combining with other zinc supplements unless clinically indicated.</li>
</ul>
<h3>Moderate Concern Requiring Active Monitoring</h3>
<p>These preparations can be clinically important in traditional practice, but the margin for error is smaller. Their use should be individualized, time-limited, and supported by batch-level testing.</p>
<ul>
<li><strong>Tamra Bhasma:</strong> Copper-based; unsuitable for casual use, prolonged unsupervised courses, or patients with copper metabolism disorders.</li>
<li><strong>Vanga Bhasma:</strong> Tin-based; requires reliable manufacturing and practitioner supervision.</li>
<li><strong>Rajata Bhasma:</strong> Silver-based; chronic unnecessary exposure should be avoided.</li>
</ul>
<h3>High Concern and Specialist Use Only</h3>
<p>Preparations containing lead, mercury, arsenic compounds, or closely related toxic mineral inputs require the highest safety threshold. They should never be treated as wellness supplements.</p>
<ul>
<li><strong>Naga Bhasma:</strong> Lead-based; lead exposure is a genuine toxicological concern even when processed.</li>
<li><strong>Parada, Rasa Sindura, Makaradhwaja, and related mercury preparations:</strong> Require expert Rasa Shastra knowledge, legal compliance, contaminant testing, clear indication, limited duration, and monitoring.</li>
<li><strong>Formulations containing arsenic minerals:</strong> Require exceptional caution and should not be used without specialist oversight.</li>
</ul>
<h2>Quality Control Recommendations for Practitioners and Patients</h2>
<p>The safest approach combines classical Rasa Shastra standards with modern laboratory quality control. Neither system should be used as a substitute for the other.</p>
<ol>
<li><strong>Use qualified supervision only:</strong> Bhasma preparations should be prescribed by a qualified Ayurvedic practitioner trained in Rasa Shastra, not self-selected from online listings.</li>
<li><strong>Demand batch-level testing:</strong> A certificate of analysis should identify the batch and include elemental testing for lead, mercury, arsenic, cadmium, and relevant intended metals.</li>
<li><strong>Prefer transparent manufacturers:</strong> The label should show batch number, manufacturing license details, ingredients, expiry, dose guidance, and safety warnings.</li>
<li><strong>Verify identity and classical quality:</strong> Classical tests such as <em>nishchandratva</em>, <em>rekhapurnatva</em>, and <em>varitaratva</em> remain useful screening tools when performed by trained practitioners.</li>
<li><strong>Avoid casual online purchase:</strong> Products sold without practitioner oversight, batch documentation, or transparent testing carry avoidable risk.</li>
<li><strong>Use the lowest appropriate dose for the shortest appropriate duration:</strong> This principle is especially important for copper-, lead-, mercury-, arsenic-, and silver-containing preparations.</li>
<li><strong>Use modern monitoring when risk is higher:</strong> Depending on the preparation, consider baseline and follow-up blood lead level, mercury level, liver function, kidney function, complete blood count, ferritin, copper status, or zinc status.</li>
<li><strong>Disclose all medicines:</strong> Patients should tell both Ayurvedic and conventional healthcare providers about bhasma use, especially before surgery, pregnancy planning, or treatment for liver, kidney, neurological, gastrointestinal, or hematologic disease.</li>
</ol>
<h2>The Nanoparticle Dimension</h2>
<p>Many bhasma discussions now use the word nanoparticle, but this needs precision. Some preparations contain nanoscale crystallites, some contain agglomerates of nanoparticles, and some measured batches show micrometre-scale particles. Particle size depends on raw material, grinding, calcination cycles, analytical method, and whether the measurement captures primary particles or agglomerates.</p>
<p>Nanoscale features may influence dissolution, surface area, tissue interaction, and dose behavior. They also add modern safety questions, because nanoscale materials can behave differently from bulk materials. For bhasma safety, particle-size claims should come from batch-specific SEM, TEM, XRD, DLS, or comparable analysis, not from the word bhasma alone.</p>
<h2>A Balanced Safety Position</h2>
<p>The most defensible position is neither to reject all bhasma as poison nor to accept all bhasma as safe. Properly prepared and properly prescribed bhasma is a distinct pharmaceutic category within Ayurveda. Poorly prepared, adulterated, mislabeled, or casually purchased products can cause real harm.</p>
<ul>
<li>Classical processing matters because incomplete incineration can leave unsuitable material.</li>
<li>Modern batch testing matters because classical tests cannot quantify lead, mercury, arsenic, cadmium, or unintended contaminants.</li>
<li>Chemical form matters because total elemental content does not equal absorbed toxic dose.</li>
<li>Patient selection matters because children, pregnant or breastfeeding patients, and people with liver, kidney, neurological, or metabolic disorders may have much higher risk.</li>
<li>Lead-, mercury-, and arsenic-containing preparations deserve the highest threshold of caution and should never be used as casual wellness supplements.</li>
</ul>
<p>For a broader discussion of how carrier substances influence Ayurvedic administration, see <a href="/science-anupana-carrier-substances-herb-pharmacokinetics/">The Science of Anupana</a>.</p>
<p><em><strong>Medical Disclaimer:</strong> This article is for educational purposes only and does not constitute medical advice. Bhasma preparations should be used only under the supervision of a qualified Ayurvedic practitioner and, when appropriate, in coordination with a conventional healthcare provider. Do not self-medicate with mineral, metal, mercury, lead, arsenic, or herbo-mineral preparations. Seek medical care promptly if you develop abdominal pain, nausea, vomiting, constipation, metallic taste, fatigue, high blood pressure, tremor, neuropathy, confusion, anemia, kidney problems, or other symptoms suggestive of heavy-metal exposure. Children, pregnant or breastfeeding people, and patients with liver, kidney, neurological, or serious chronic illness should avoid bhasma unless a qualified specialist determines that use is appropriate and monitored.</em></p>
<h2>References</h2>
<ol>
<li><a href="https://pdfs.semanticscholar.org/e367/18d0d68d53d88f9e70de34c4f9a0401a5086.pdf" rel="nofollow noopener noreferrer" target="_blank">Pdfs (pdfs.semanticscholar.org)</a></li>
<li><a href="https://pdfs.semanticscholar.org/4ee2/e8c83bcbbf07d471e4da95da301ccc94f656.pdf" rel="nofollow noopener noreferrer" target="_blank">Pdfs (pdfs.semanticscholar.org)</a></li>
<li><a href="https://aamjournal.in/fulltext/70-1428935346.pdf" rel="nofollow noopener noreferrer" target="_blank">Aamjournal (aamjournal.in)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6314242/" rel="nofollow noopener noreferrer" target="_blank">Assessment of bioavailability of gold bhasma in human participants &#8211; A pilot study (2018), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/18728265/" rel="nofollow noopener noreferrer" target="_blank">Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2755212/" rel="nofollow noopener noreferrer" target="_blank">Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? (2008), PubMed Central</a></li>
<li><a href="https://www.fda.gov/drugs/fraudulent-products/fda-warns-about-heavy-metal-poisoning-associated-certain-unapproved-ayurvedic-drug-products" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://ayush.delhi.gov.in/faqs/ayurveda" rel="nofollow noopener noreferrer" target="_blank">Ayush (ayush.delhi.gov.in)</a></li>
<li><a href="https://www.pib.gov.in/newsite/erelcontent.aspx?relid=45782" rel="nofollow noopener noreferrer" target="_blank">Pib (pib.gov.in)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/22561344/" rel="nofollow noopener noreferrer" target="_blank">Scientific validation of the different purification steps involved in the preparation of an Indian Ayurvedic medicine, Lauha bhasma (2012), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9978626/" rel="nofollow noopener noreferrer" target="_blank">Structural investigation of Ayurveda Lauha (Iron) Bhasma (2023), PubMed Central</a></li>
<li><a href="https://mail.greenpharmacy.info/index.php/ijgp/article/view/1357/795" rel="nofollow noopener noreferrer" target="_blank">Mail (mail.greenpharmacy.info)</a></li>
<li><a href="https://www.ijpsonline.com/articles/scientific-insights-in-the-preparation-and-characterisation-of-a-leadbased-inaga-bhasmai.html" rel="nofollow noopener noreferrer" target="_blank">Ijpsonline (ijpsonline.com)</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/heavy-metal-content-bhasma-preparations-icp-ms-safety-data/feed/</wfw:commentRss>
			<slash:comments>31</slash:comments>
		
		
			</item>
		<item>
		<title>Rasa Tarangini Herb Guide: 10 Minerals and Their Ayurvedic Therapeutic Applications</title>
		<link>https://www.ayurvedhealing.com/rasa-tarangini-herb-guide-minerals-ayurvedic-applications/</link>
					<comments>https://www.ayurvedhealing.com/rasa-tarangini-herb-guide-minerals-ayurvedic-applications/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Sun, 12 Jul 2026 07:30:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Bhasma]]></category>
		<category><![CDATA[Classical Texts]]></category>
		<category><![CDATA[Mineral Medicine]]></category>
		<category><![CDATA[Minerals]]></category>
		<category><![CDATA[pharmacology]]></category>
		<category><![CDATA[Rasa Shastra]]></category>
		<category><![CDATA[Rasa Tarangini]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=2908</guid>

					<description><![CDATA[Rasa Tarangini, attributed to Sadananda Sharma, is one of the important later Rasa Shastra texts of Ayurveda. It gathers pharmaceutical methods for substances such as Parada, Swarna, Rajata, Tamra, Loha, Mandura, Vanga, Abhraka, Shilajatu, Praval and many other mineral, metal and gem materials, with repeated attention to purification, incineration, dose, vehicle and disease-context. Its value [&#8230;]]]></description>
										<content:encoded><![CDATA[<p><em>Rasa Tarangini</em>, attributed to Sadananda Sharma, is one of the important later Rasa Shastra texts of Ayurveda. It gathers pharmaceutical methods for substances such as Parada, Swarna, Rajata, Tamra, Loha, Mandura, Vanga, Abhraka, Shilajatu, Praval and many other mineral, metal and gem materials, with repeated attention to purification, incineration, dose, vehicle and disease-context. Its value is practical and pharmaceutical: it does not treat raw metals as ordinary supplements, but as substances requiring classical processing before internal use.</p>
<p>What follows is a clinically oriented review of ten key mineral and mineral-adjacent preparations associated with the <em>Rasa Tarangini</em> tradition. The focus is on verified classical indications, corrected safety context and cautious contemporary interpretation. This is not a guide to self-administration.</p>
<h2>The Critical Safety Premise</h2>
<p>Rasa Shastra medicines made from metals, minerals, gems and mineral exudates are not equivalent to the raw substances from which they begin. Classical pharmacy uses procedures such as <em>Shodhana</em> (purification), <em>Bhavana</em> (levigation with liquid media) and <em>Marana</em> (incineration/calcination) before a material is considered fit for internal administration. Finished Bhasma is also evaluated through traditional quality tests and, in responsible contemporary practice, through modern quality-control testing for identity, particle character and toxic contaminants.</p>
<p>This distinction is clinically important but not a licence for casual use. Inadequately processed, adulterated or contaminated Ayurvedic metal/mineral products have been associated with lead, mercury, arsenic and other heavy-metal exposure. Any Bhasma or herbo-mineral medicine should be used only when prescribed by a qualified Ayurvedic physician and sourced from a licensed manufacturer that provides appropriate quality testing.</p>
<h2>1. Swarna Bhasma (Purified Gold Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> describes properly prepared Swarna Bhasma as <em>madhura</em>, <em>vrishya</em>, <em>hridya</em>, <em>netrya</em>, <em>medhya</em>, <em>rasayana</em>, supportive of <em>smriti</em>, <em>vayasthapana</em> and useful in wasting conditions. The text also presents it as a high-value Rasayana drug used in small, physician-adjusted doses with suitable <em>anupana</em>.</p>
<p><strong>Contemporary description:</strong> Characterised samples of Swarna Bhasma have shown gold-containing particles with nanoscale crystallites in some preparations, while other analyses describe a broader range of particle sizes depending on the manufacturing method. Laboratory work has also examined blood compatibility and macrophage-related immune activity, which aligns with the classical placement of Swarna among strengthening and Rasayana medicines, but it does not justify unsupervised use.</p>
<p><strong>Clinical caution:</strong> Swarna Bhasma is among the most potent and expensive Bhasma preparations and should be reserved for clear indications, correct diagnosis and verified sourcing. It is inappropriate as a general wellness supplement without medical supervision, especially in children, pregnancy, kidney disease, liver disease or immunological disorders.</p>
<h2>2. Rajata Bhasma (Silver Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> describes Rajata after purification and processing as cooling, strengthening, <em>medhya</em>, supportive in <em>shukrameha</em>, <em>prameha</em>, old fevers, certain spleen/abdominal disorders, wasting conditions and selected nervous-system presentations. The text also warns that silver requires proper purification before internal use.</p>
<p><strong>Contemporary description:</strong> Silver nanoparticles are well known in biomedical literature for broad antimicrobial material activity. That property should not be automatically transferred to every marketed Rajata Bhasma product, because particle size, chemical form, contaminants and processing quality vary by batch and manufacturer.</p>
<p><strong>Clinical caution:</strong> Long-term or excessive silver exposure can cause argyria, an often irreversible blue-grey discoloration of skin and mucous membranes. Rajata Bhasma should therefore be used only in small classical doses, for a defined indication, and under professional supervision.</p>
<h2>3. Tamra Bhasma (Copper Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> is especially clear that unpurified copper is unsafe. It describes improper copper exposure as capable of causing nausea, vomiting, dizziness, heat, tissue depletion, diarrhoea and fainting. Properly prepared Tamra Bhasma is described as <em>tikta</em>, <em>kashaya</em>, <em>madhura</em>, <em>ushna</em>, <em>lekhana</em>, <em>saraka</em>, and useful in conditions involving <em>yakrit</em>, <em>pliha</em>, <em>udara</em>, <em>pandu</em>, <em>kasa</em>, <em>shwasa</em>, <em>krimi</em>, <em>kushta</em>, <em>grahani</em> and <em>sthaulya</em>.</p>
<p><strong>Contemporary description:</strong> Physicochemical work on Tamra Bhasma has described nanocrystalline copper-containing material and in-vitro antibacterial activity in some prepared samples. This supports the importance of processing and standardisation, not the use of crude copper or untested products.</p>
<p><strong>Clinical caution:</strong> Copper has a narrower safety margin than many other mineral preparations. People with copper-metabolism disorders, including Wilson disease, should avoid copper-containing preparations unless a specialist explicitly advises otherwise. Extended use requires clinical judgment and appropriate monitoring.</p>
<h2>4. Loha Bhasma (Iron Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> describes Loha Bhasma as <em>tikta-kashaya</em>, <em>madhura vipaka</em>, <em>shita virya</em>, <em>lekhana</em>, <em>balya</em>, <em>vrishya</em>, <em>netrya</em> and <em>medhya</em>. Its major clinical placement is in <em>pandu</em>, <em>kamala</em>, <em>yakrit</em>-related weakness, <em>pliha</em> disorders, <em>meha</em>, <em>arsha</em>, <em>shwasa</em>, <em>kshaya</em> and strength-depleting conditions. Classical combinations often pair Loha with substances such as Triphala, honey, ghee, Haritaki, Katuki or other disease-specific vehicles.</p>
<p><strong>Contemporary description:</strong> Structural analysis of medicinal-grade Lauha/Loha Bhasma has identified iron-oxide phases such as magnetite, often present as agglomerates of nanoscale particles. This is chemically different from simply swallowing metallic iron filings and also different from ordinary ferrous sulphate tablets.</p>
<p><strong>Clinical caution:</strong> Loha Bhasma should not be used blindly for fatigue. Anaemia has many causes, and iron-containing preparations are unsuitable in iron-overload states such as hereditary haemochromatosis, hemosiderosis and some haemolytic conditions. Diagnosis and monitoring are essential.</p>
<h2>5. Abhraka Bhasma (Mica Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> places Abhraka in the mica section and gives multiple processing methods involving repeated <em>puta</em> cycles. It describes properly prepared Abhraka Bhasma as <em>snigdha</em>, <em>shishira</em>, <em>svadu</em>, <em>ayushya</em>, <em>keshya</em>, <em>varnya</em>, <em>ruchikara</em>, <em>dipana</em>, <em>balya</em>, <em>netrya</em>, <em>medhya</em>, and useful in <em>jwara</em>, <em>rajayakshma</em>, <em>kasa</em>, <em>shwasa</em>, <em>raktapitta</em>, <em>grahani</em>, <em>pandu</em>, <em>halimaka</em> and <em>meha</em>.</p>
<p><strong>Contemporary description:</strong> Characterisation of Abhraka Bhasma preparations has identified micro- and nanoscale mineral particles, with one analytical study describing a substantial fraction in the 50–500 nm range. The number of heating cycles, raw mica quality and processing media can materially change the finished product.</p>
<p><strong>Clinical caution:</strong> Abhraka Bhasma should not be chosen by name alone. Batch quality, degree of processing, absence of gritty material and contaminant testing matter. Respiratory, wasting and Rasayana indications require professional assessment rather than self-selection.</p>
<h2>6. Vanga Bhasma (Tin Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> describes Vanga Bhasma as generally light, cooling, dry, <em>medhya</em>, <em>tikta-kashaya</em> with slight saltiness, <em>ruchikara</em>, <em>kaphahara</em> and useful in <em>prameha</em>, excessive urinary or reproductive discharges, <em>shukra</em>-related debility, <em>pandu</em>, chronic cough/respiratory difficulty and certain <em>krimi</em> presentations. The text also notes that processing media can influence whether the finished preparation behaves more cooling or heating.</p>
<p><strong>Contemporary description:</strong> Vanga Bhasma remains primarily a classical genitourinary and <em>prameha</em>-oriented preparation rather than a general diabetes supplement. Its use depends heavily on <em>roga</em>, <em>dosha</em>, <em>dushya</em>, urinary findings, reproductive tissue assessment and the selected <em>anupana</em>.</p>
<p><strong>Clinical caution:</strong> Tin-containing preparations require the same caution as other metallic Bhasma. They should not be used for urinary symptoms without ruling out infection, kidney disease, diabetes complications, prostate disease or other biomedical causes.</p>
<h2>7. Mandura Bhasma (Processed Iron Rust / Iron Oxide Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> describes Mandura Bhasma after purification and incineration as <em>vrishya</em>, <em>shishira</em>, <em>ruchira</em>, <em>dipana</em>, <em>pitta-shamana</em> and <em>raktavardhaka</em>. It is classically used in <em>pandu</em>, <em>kamala</em>, <em>shotha</em>, <em>shosha</em>, <em>halimaka</em> and <em>pliha</em>-related disorders, often with Triphala, Punarnava, Katuki, Vidanga or other disease-specific herbs.</p>
<p><strong>Contemporary description:</strong> Mandura is an iron-based preparation, traditionally distinguished from Loha Bhasma by its raw material and processing context. Its classical placement is especially relevant where anaemia-like presentations are associated with liver, spleen, oedema or digestive impairment patterns.</p>
<p><strong>Clinical caution:</strong> Mandura Bhasma should be avoided in iron-overload conditions and should not replace diagnostic work-up for anaemia, jaundice, oedema or liver disease. Laboratory assessment is important when symptoms suggest systemic disease.</p>
<h2>8. Parada Preparations (Mercury-Based Medicines)</h2>
<p>Parada is central to Rasa Shastra literature, but it is also the most safety-sensitive category. Raw mercury is toxic and is not treated as an ordinary supplement. Classical processing includes purification and combinations such as mercury-sulphur triturations in the wider Rasa Shastra tradition; preparations such as Kajjali and Rasasindura require specialised pharmacy, identity testing and expert use.</p>
<p>My clinical position is conservative: Parada-based preparations should be considered only in exceptional, clearly justified cases under a highly qualified physician, with lawful sourcing and laboratory testing. In many jurisdictions, products containing mercury or excessive heavy metals may be detained, restricted or considered unsafe. Plant-based and non-mercurial options are preferable for most routine conditions.</p>
<h2>9. Shilajit / Shilajatu (Mineral Pitch; Semi-Mineral Rasayana)</h2>
<p>Shilajit is not a Bhasma; it is a mineral exudate included in the Rasa Shastra pharmaceutic world. <em>Rasa Tarangini</em> discusses its purification, tests for purified material, properties and use. The text describes purified Shilajatu as predominantly <em>tikta</em>, <em>katu vipaka</em>, especially <em>mutrala</em>, <em>yogavahi</em> and <em>rasayana</em>, with uses in <em>mutrakrichra</em>, <em>mutraghata</em>, <em>ashmari</em>, <em>prameha</em>, <em>sthaulya</em>, heart-related indications and reproductive weakness depending on formulation and vehicle.</p>
<p><strong>Contemporary description:</strong> Purified Shilajit contains humic substances including fulvic acid and has been evaluated in controlled human work. A randomised, double-blind, placebo-controlled trial using purified Shilajit at 250 mg twice daily for 90 days reported increases in total testosterone, free testosterone and DHEAS in healthy male volunteers. Other work has examined fatigue-related performance and mitochondrial models, but product purity remains central.</p>
<p><strong>Clinical caution:</strong> Unpurified or adulterated Shilajit may contain heavy metals, mineral grit or other contaminants. Only purified, tested products should be used, and people with kidney disease, gout tendency, high uric acid, iron overload, pregnancy, lactation or complex chronic illness should consult a qualified practitioner before use.</p>
<h2>10. Praval Bhasma (Coral Calx)</h2>
<p><strong>Classical profile:</strong> <em>Rasa Tarangini</em> describes Praval/Vidruma after proper preparation as <em>madhura</em>, light, cooling, <em>dipana</em>, <em>pachana</em>, beneficial for eye disorders, <em>tridosha-shamana</em> with special effect on Kapha-Vata, <em>balya</em>, useful in <em>kshaya-kasa</em>, <em>raktapitta</em>, excess sweating and night sweating. It is also traditionally associated with Pitta-calming, cooling and calcium-supportive contexts.</p>
<p><strong>Contemporary description:</strong> Analytical work on Praval Bhasma has shown transformation of coral-derived calcium carbonate material during processing, with finished products differing from raw coral in particle size and chemical character. It should therefore be understood as a processed calcium-rich Ayurvedic preparation rather than ordinary coral powder.</p>
<p><strong>Clinical caution:</strong> Praval Bhasma is generally considered gentler than many metallic Bhasma, but it still requires quality assurance. People with kidney stones, chronic kidney disease, hypercalcaemia, sarcoidosis, parathyroid disorders or those taking calcium/vitamin D therapeutically should avoid casual use.</p>
<h2>Comparative Safety Reference</h2>
<p>The following table summarises the practical safety position for these preparations. “Contemporary support” refers to available analytical, experimental or limited human data; it does not mean a preparation is appropriate without diagnosis, sourcing control and physician oversight.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse; margin:20px 0;">
<thead style="background-color:#f5f0e8;">
<tr>
<th>Preparation</th>
<th>Classical Emphasis</th>
<th>Contemporary Support</th>
<th>Safety Position</th>
<th>Physician Supervision</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swarna Bhasma</td>
<td>Rasayana, Medhya, Ojas/supportive strength</td>
<td>Analytical and laboratory immune/cell work</td>
<td>High-value, potent, small-dose medicine</td>
<td>Mandatory</td>
</tr>
<tr>
<td>Rajata Bhasma</td>
<td>Cooling, Medhya, Prameha and nervous indications</td>
<td>Silver nanoparticle antimicrobial literature; limited direct clinical evidence</td>
<td>Argyria risk with excess or poor-quality silver exposure</td>
<td>Mandatory</td>
</tr>
<tr>
<td>Tamra Bhasma</td>
<td>Yakrit-Pliha, Pandu, Krimi, Kapha-Pitta disorders</td>
<td>Physicochemical and in-vitro antibacterial work</td>
<td>Narrow safety margin; avoid copper-metabolism disorders</td>
<td>Mandatory</td>
</tr>
<tr>
<td>Loha Bhasma</td>
<td>Pandu, Kamala, strength and blood-supportive use</td>
<td>Structural iron-oxide characterisation</td>
<td>Avoid iron overload; diagnose anaemia first</td>
<td>Mandatory</td>
</tr>
<tr>
<td>Abhraka Bhasma</td>
<td>Rasayana, respiratory/wasting and Medhya use</td>
<td>Particle and mineral characterisation</td>
<td>Quality depends strongly on processing cycles and testing</td>
<td>Mandatory</td>
</tr>
<tr>
<td>Vanga Bhasma</td>
<td>Prameha, urinary/reproductive tissue support</td>
<td>Mainly classical and pharmaceutic support</td>
<td>Not for undiagnosed urinary symptoms</td>
<td>Mandatory</td>
</tr>
<tr>
<td>Mandura Bhasma</td>
<td>Pandu, Kamala, Shotha, Pliha/Yakrit contexts</td>
<td>Classical and iron-based pharmaceutic support</td>
<td>Avoid iron overload and unexplained jaundice/oedema</td>
<td>Mandatory</td>
</tr>
<tr>
<td>Parada preparations</td>
<td>Specialised Rasa Shastra medicines</td>
<td>Highest safety and regulatory concern</td>
<td>Exceptional use only; mercury testing essential</td>
<td>Mandatory specialist care</td>
</tr>
<tr>
<td>Shilajit</td>
<td>Mutrala, Yogavahi, Rasayana, Prameha/urinary use</td>
<td>Limited human trials and experimental work</td>
<td>Use only purified, contaminant-tested material</td>
<td>Recommended; mandatory in illness</td>
</tr>
<tr>
<td>Praval Bhasma</td>
<td>Cooling, Pitta/Raktapitta, cough/wasting, calcium-supportive use</td>
<td>Calcium-rich material characterisation</td>
<td>Caution in kidney stones, kidney disease and calcium disorders</td>
<td>Recommended</td>
</tr>
</tbody>
</table>
<p><em>This article is for educational purposes only. Mineral, metal, gem and herbo-mineral preparations should be used only under the guidance of a qualified Ayurvedic practitioner or healthcare provider. Self-administration of heavy metal-based preparations is dangerous. Pregnant women, nursing mothers, children, older adults, and individuals with kidney disease, liver disease, metabolic disorders or unexplained symptoms should avoid Bhasma preparations unless under direct specialist care.</em></p>
<h2>References</h2>
<ol>
<li><a href="https://archive.org/details/qofQ_rasa-taarngini-of-sadananda-sharma-ed-by-kashinath-shastri-with-prasadani-annota" rel="nofollow noopener noreferrer" target="_blank">Archive (archive.org)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3960793/" rel="nofollow noopener noreferrer" target="_blank">Bhasma : The ancient Indian nanomedicine (2014), PubMed Central</a></li>
<li><a href="https://www.nccih.nih.gov/health/ayurvedic-medicine-in-depth" rel="nofollow noopener noreferrer" target="_blank">NCCIH</a></li>
<li><a href="https://www.fda.gov/drugs/fraudulent-products/fda-warns-about-heavy-metal-poisoning-associated-certain-unapproved-ayurvedic-drug-products" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://archive.org/stream/qofQ_rasa-taarngini-of-sadananda-sharma-ed-by-kashinath-shastri-with-prasadani-annota/Rasa%20Taarngini%20Of%20Sadananda%20Sharma%20Ed%20By%20Kashinath%20Shastri%20With%20Prasadani%20Annotation%20Of%20Haridatta%20Shastri%2C%20Hindi%20Notes%20By%20Dharmananda%20Shastri%2C%201979%20-%20Motilal%20Banarsidas%2C%20Delhi_djvu.txt" rel="nofollow noopener noreferrer" target="_blank">Archive (archive.org)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3157103/" rel="nofollow noopener noreferrer" target="_blank">Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed Central</a></li>
<li><a href="https://www.nature.com/articles/s41598-017-10872-3" rel="nofollow noopener noreferrer" target="_blank">Nature (nature.com)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10123016/" rel="nofollow noopener noreferrer" target="_blank">Swarna Bhasma Induces Antigen-Presenting Abilities of Macrophages and Helps Antigen Experienced CD4(+) T Cells to Acquire Th1 Phenotypes Against Leishmania donovani Antigens (2024), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7080016/" rel="nofollow noopener noreferrer" target="_blank">Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (2014), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5541471/" rel="nofollow noopener noreferrer" target="_blank">Physicochemical characterization and antibacterial activity of Rajata Bhasma and silver nanoparticle (2016), PubMed Central</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/books/NBK604211/" rel="nofollow noopener noreferrer" target="_blank">NCBI</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6598801/" rel="nofollow noopener noreferrer" target="_blank">Study on physical properties of Ayurvedic nanocrystalline Tamra Bhasma by employing modern scientific tools (2019), PubMed Central</a></li>
<li><a href="https://arxiv.org/abs/2207.14615" rel="nofollow noopener noreferrer" target="_blank">Arxiv (arxiv.org)</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/books/NBK557376/" rel="nofollow noopener noreferrer" target="_blank">NCBI</a></li>
<li><a href="https://europepmc.org/article/pmc/pmc7527821" rel="nofollow noopener noreferrer" target="_blank">Europepmc (europepmc.org)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3530268/" rel="nofollow noopener noreferrer" target="_blank">Physicochemical characterization of an Iron based Indian traditional medicine: Mandura Bhasma (2011), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/26395129/" rel="nofollow noopener noreferrer" target="_blank">Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers (2016), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6364418/" rel="nofollow noopener noreferrer" target="_blank">The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels (2019), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/24461595/" rel="nofollow noopener noreferrer" target="_blank">In-house preparation and characterization of an Ayurvedic bhasma: Praval bhasma (2014), PubMed</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/rasa-tarangini-herb-guide-minerals-ayurvedic-applications/feed/</wfw:commentRss>
			<slash:comments>34</slash:comments>
		
		
			</item>
		<item>
		<title>Exosome Delivery and Bhasma Nanoparticles: 2026 Research Frontiers</title>
		<link>https://www.ayurvedhealing.com/exosome-delivery-bhasma-nanoparticles-ayurveda-2026/</link>
					<comments>https://www.ayurvedhealing.com/exosome-delivery-bhasma-nanoparticles-ayurveda-2026/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Thu, 02 Jul 2026 10:30:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Bhasma]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Exosomes]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Pharmacology Research]]></category>
		<category><![CDATA[Rasa Shastra]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=2860</guid>

					<description><![CDATA[Plant-derived exosome-like nanoparticles have become a useful modern comparison point for understanding why some classical Ayurvedic mineral preparations deserve careful analytical attention. These plant nanovesicles are lipid-membrane particles that can carry proteins, lipids, RNA, and plant metabolites; well-prepared Bhasma, by contrast, is a calcined mineral or metal preparation whose final behaviour depends on particle size, [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>Plant-derived exosome-like nanoparticles have become a useful modern comparison point for understanding why some classical Ayurvedic mineral preparations deserve careful analytical attention. These plant nanovesicles are lipid-membrane particles that can carry proteins, lipids, RNA, and plant metabolites; well-prepared Bhasma, by contrast, is a calcined mineral or metal preparation whose final behaviour depends on particle size, crystalline phase, surface chemistry, and the classical media used during processing.</p>
<p>The comparison is not that Bhasma is an exosome. It is more precise to say that both fields force the same pharmacological question: how can a small, structured particle survive biological environments, interact with cellular barriers, and produce effects that are different from the unprocessed raw material? Rasa Shastra approached this question through Shodhana, Bhavana, Marana, and Bhasma Pariksha. Modern nanomedicine approaches it through XRD, SEM, TEM, DLS, zeta potential, spectroscopy, and biological assays.</p>
<h2>What Is Bhasma? The Classical Process Revisited</h2>
<p>Bhasma is a calcined preparation made from metals, minerals, gems, shells, or related substances after classical purification and incineration procedures. In Rasa Shastra, the raw substance is not used casually; it is repeatedly purified, triturated with prescribed liquids or herbal media, formed into pellets when required, and heated through controlled cycles until the material becomes a fine, stable ash suitable for medicinal use under expert supervision.</p>
<p>Classical quality tests remain central to the identity of Bhasma. <strong>Varitara</strong> assesses lightness by whether the fine powder can float on still water. <strong>Rekhapurnatva</strong> assesses fineness by whether the powder enters the lines of the fingers. <strong>Nishchandratva</strong> assesses absence of metallic lustre. <strong>Apunarbhava</strong> and <strong>Niruttha</strong> assess whether the material resists reversion to its original metallic state. These tests do not replace modern analysis, but they show that particle fineness, stability, and complete transformation were already built into classical quality control.</p>
<h2>Where the Nanoparticle Discussion Fits</h2>
<p>Modern analytical work on Bhasma has found that some preparations contain nanoscale crystallites, nano-sized particles, or nano-sized substructures within larger aggregates. This does not mean every commercial Bhasma is automatically a therapeutic nanoparticle. Particle size can vary widely between batches and manufacturers, and the same Bhasma name can refer to products with different elemental composition, morphology, and biological behaviour.</p>
<p>This is why the most useful modern framing is not “ancient Ayurveda already made perfect nanoparticles,” but rather: Rasa Shastra created repeatable pharmaceutical processes that can transform metals and minerals into fine, chemically altered, biologically distinctive preparations. Nanoscience gives us tools to describe those transformations more clearly.</p>
<h2>The Exosome Parallel: Size, Structure, and Biological Transport</h2>
<p>Exosomes are small extracellular vesicles, commonly described in the range of about 30–150 nm, secreted by cells and carrying nucleic acids, proteins, lipids, and metabolites. Plant-derived exosome-like nanoparticles from edible plants such as ginger, grape, grapefruit, carrot, lemon, and others are being explored as natural carriers because their lipid membrane can protect cargo and help cellular uptake.</p>
<p>Ginger-derived nanoparticles are a useful comparison because they have been characterised as natural, lipid-rich carriers containing plant bioactives and small RNAs, with uptake by intestinal epithelial cells and macrophages in preclinical models. Their biological behaviour is linked not only to size, but also to membrane composition and surface interaction with cells.</p>
<p>Bhasma preparations differ completely in origin and structure: they are inorganic or herbo-mineral calcined materials, not lipid vesicles. Still, the comparison highlights an important principle: the biological behaviour of a medicine can depend on the whole particle system, including size, surface chemistry, aggregation, charge, and processing history, not merely on the name of the element.</p>
<h2>Swarna Bhasma: The Most Studied Preparation</h2>
<p><strong>Swarna Bhasma</strong>, the classical calcined gold preparation, has received the most modern attention because gold is easier to track with contemporary analytical tools. Reports on Swarna Bhasma have described gold crystallites in the nanometre range in some preparations, while other studies have found larger aggregates and substantial manufacturer-to-manufacturer variation.</p>
<p>One blood compatibility study described Swarna Bhasma preparations with gold crystallite size around 28–35 nm and reported no blood cell aggregation, no protein adsorption, negligible complement and platelet activation, and non-cytotoxic behaviour in the tested in vitro systems. Another cell-entry study found that incinerated Swarna Bhasma particles differed from chemically synthesised gold nanoparticles; individual crystallites were around 60 nm, but the material formed much larger irregular aggregates and entered cells through endocytosis-related pathways.</p>
<p>The practical lesson is important: Swarna Bhasma cannot be understood as simple gold powder. Its behaviour depends on how the gold is processed, what secondary elements or organic residues remain, whether the particles are nanoscale or aggregated, and whether the final product has passed both classical and modern quality checks.</p>
<h2>Abhraka Bhasma: Mica Transformed Through Processing</h2>
<p><strong>Abhraka Bhasma</strong> is prepared from mica. Classical Ayurveda places it among important Rasayana-oriented mineral preparations, especially in formulations concerned with strength, respiratory resilience, tissue nourishment, and chronic debility. Its traditional prestige is tied to repeated purification and incineration cycles, including higher-cycle preparations such as Shataputi or Sahasraputi Abhraka in classical practice.</p>
<p>Modern analytical reports on Abhraka Bhasma describe major mineral elements such as iron, silicon, aluminium, potassium, magnesium, calcium, and related oxide or silicate phases depending on the source and process. Some FEG-SEM reports describe heterogeneous aggregates with particles in the nanometre range, while other analyses report broader micro-to-nano distributions. This supports the classical idea that mica is not simply powdered and consumed; it is transformed into a different processed material.</p>
<p>It is more accurate to call Abhraka Bhasma a complex mica-derived herbo-mineral preparation than an “iron-free but iron-equivalent” medicine. Its classical use is not reducible to iron replacement, and its modern profile is not yet defined by a single confirmed pathway.</p>
<h2>Tamra Bhasma and Copper-Based Nanocrystalline Materials</h2>
<p><strong>Tamra Bhasma</strong> is the classical calcined copper preparation. It is among the Bhasmas where safety discipline is especially important, because improperly processed copper preparations can be harmful. Classical Rasa Shastra therefore gives strong importance to purification, incineration, and testing before use.</p>
<p>Analytical work on Tamra Bhasma has characterised it as a copper-based preparation containing copper compounds such as copper oxides and related phases, with nanocrystalline features reported in some samples. Preliminary antimicrobial testing has reported activity against bacteria, but this should be read as early laboratory work rather than a reason for self-medication.</p>
<p>The modern antimicrobial interest in copper nanoparticles gives Tamra Bhasma a plausible research context, but the Ayurvedic medicine cannot be equated casually with chemically synthesised copper nanoparticles. Processing media, final chemical form, dose, particle size, and purity all matter.</p>
<h2>Lauha Bhasma: Iron After Classical Transformation</h2>
<p><strong>Lauha Bhasma</strong> is the classical calcined iron preparation and is traditionally used in conditions corresponding to Pandu and iron-deficiency states under Ayurvedic diagnosis. Modern structural work has reported that metallic iron can transform through processing into iron oxide phases such as magnetite or related iron oxides, often appearing as agglomerates of nano-sized particles.</p>
<p>This supports a key Rasa Shastra principle: metals are not intended to be used in crude metallic form. The point of Bhasmikarana is transformation into a form that is finer, chemically altered, and suitable for carefully supervised therapeutic use.</p>
<h2>Vanga Bhasma and the Limits of Mechanistic Claims</h2>
<p><strong>Vanga Bhasma</strong>, the calcined tin preparation, is classically used in selected genitourinary, metabolic, and reproductive contexts depending on the formulation and diagnosis. Analytical reports describe porous or granular particles and tin-containing phases in some preparations, but the modern pharmacological mechanism is not yet settled.</p>
<p>Because of that uncertainty, it is better to discuss Vanga Bhasma as an important classical preparation needing stronger analytical and clinical standardisation, rather than assigning it a speculative mechanism such as “tin-ion glycaemic modulation.”</p>
<h2>The Blood-Brain Barrier Question</h2>
<p>The blood-brain barrier is one of the major obstacles in drug delivery because it restricts entry of many small-molecule and large-molecule therapeutics into the brain. Nanomedicine research therefore pays close attention to particle size, surface charge, surface ligands, shape, and transcytosis pathways.</p>
<p>Some gold nanoparticle systems can be engineered for cellular uptake and barrier transport, and Swarna Bhasma has been studied for cellular entry. However, a direct clinical claim that Swarna Bhasma crosses the human blood-brain barrier or treats neurodegenerative disease through such a pathway would go beyond the established evidence. The safer, more accurate position is that Swarna Bhasma is a meaningful candidate for further mechanistic work because its classical use, gold content, particle behaviour, and modern gold-nanoparticle literature overlap in interesting ways.</p>
<h2>Quality Control: The Critical Gap</h2>
<p>Quality control is the point where classical Ayurveda and modern safety science must meet. A Bhasma may be beautifully described in a text, but the commercial product in a bottle is only as reliable as its raw material selection, purification, incineration, batch control, contamination testing, and final verification.</p>
<p>Modern studies of commercial Ayurvedic preparations have documented serious risks from lead, mercury, arsenic, and other metals in some products. Even within a single category such as Suvarna Bhasma, manufacturer-to-manufacturer differences in size, shape, composition, gold percentage, and bioaccumulation profile have been reported. Therefore, a responsible Bhasma recommendation requires a qualified Ayurvedic physician, a reputable manufacturer, GMP-level production, and analytical documentation for identity, purity, and safety.</p>
<h2>Current Status and Research Needs</h2>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%; border-collapse:collapse;">
<thead>
<tr style="background-color:#f5f0e8;">
<th>Bhasma Type</th>
<th>Modern Analytical Status</th>
<th>Most Relevant Modern Lens</th>
<th>Next Needed Work</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swarna Bhasma</td>
<td>Analytical, in vitro, cell-entry, blood compatibility, and animal pharmacokinetic work</td>
<td>Gold crystallites, aggregation, cellular uptake, batch variation</td>
<td>Standardised preparations, pharmacokinetics, safety, and controlled clinical trials</td>
</tr>
<tr>
<td>Abhraka Bhasma</td>
<td>Analytical and compositional work with variable particle-size reporting</td>
<td>Mica-derived silicate and oxide transformation</td>
<td>Bioaccessibility, toxicity, and formulation-specific clinical evaluation</td>
</tr>
<tr>
<td>Tamra Bhasma</td>
<td>Analytical and preliminary antimicrobial work</td>
<td>Copper oxide and copper-based nanocrystalline material</td>
<td>Safety margins, dose discipline, and batch-to-batch standardisation</td>
</tr>
<tr>
<td>Lauha Bhasma</td>
<td>Structural and chemical work on iron oxide phases</td>
<td>Iron transformation into oxide phases and nano-agglomerates</td>
<td>Human bioavailability and comparison with standard iron therapy</td>
</tr>
<tr>
<td>Vanga Bhasma</td>
<td>Limited analytical and pharmaceutico-chemical work</td>
<td>Tin-containing calcined preparation</td>
<td>Mechanism, safety, and controlled clinical relevance</td>
</tr>
</tbody>
</table>
<h2>References and Further Reading</h2>
<ul>
<li>Pal D, Sahu CK, Haldar A. <em>Bhasma: The ancient Indian nanomedicine.</em> Journal of Advanced Pharmaceutical Technology &amp; Research. 2014.</li>
<li>Paul W, Sharma CP. <em>Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug.</em> International Journal of Ayurveda Research. 2011.</li>
<li>Beaudet D et al. <em>Comparative study on cellular entry of incinerated ancient gold particles (Swarna Bhasma) and chemically synthesized gold particles.</em> Scientific Reports. 2017.</li>
<li>Biswas S et al. <em>Physicochemical Variation in Nanogold-Based Ayurved Medicine Suvarna Bhasma Produced by Various Manufacturers Lead to Different In Vivo Bioaccumulation Profiles.</em> Journal of Evidence-Based Integrative Medicine. 2021.</li>
<li>Wadekar MP et al. <em>Preparation and characterization of a copper based Indian traditional drug: Tamra bhasma.</em> Journal of Pharmaceutical and Biomedical Analysis. 2005.</li>
<li>Singh RK et al. <em>Study on physical properties of Ayurvedic nanocrystalline Tamra Bhasma by employing modern scientific tools.</em> Journal of Ayurveda and Integrative Medicine. 2019.</li>
<li>Tiwari MK et al. <em>Structural investigation of Ayurveda Lauha (Iron) Bhasma.</em> Scientific Reports. 2023.</li>
<li>Zhang M et al. <em>Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.</em> Biomaterials. 2016.</li>
<li>Kalluri R, LeBleu VS. <em>The biology, function, and biomedical applications of exosomes.</em> Science. 2020.</li>
<li>Hersh AM et al. <em>Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.</em> International Journal of Molecular Sciences. 2022.</li>
</ul>
<p><em>Safety disclaimer: Bhasma preparations, especially those containing metals such as gold, copper, iron, mercury, arsenic, or lead-containing ingredients in classical formulations, must only be used under the supervision of a qualified Ayurvedic physician and appropriate healthcare provider. Do not self-medicate with Bhasma or buy unverified products. This article is educational and does not diagnose, treat, prescribe, or recommend any specific product.</em></p>
<h2>References</h2>
<ol>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3960793/" rel="nofollow noopener noreferrer" target="_blank">Bhasma : The ancient Indian nanomedicine (2014), PubMed Central</a></li>
<li><a href="https://pcimh.gov.in/show_content.php?lang=1&#038;level=1&#038;lid=54&#038;ls_id=56" rel="nofollow noopener noreferrer" target="_blank">Ayurvedic Pharmacopoeia of India</a></li>
<li><a href="https://pcimh.gov.in/show_content.php?lang=1&#038;level=1&#038;lid=54&#038;ls_id=56&#038;utm_source=chatgpt.com" rel="nofollow noopener noreferrer" target="_blank">Ayurvedic Pharmacopoeia of India</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7717626/" rel="nofollow noopener noreferrer" target="_blank">The biology, function, and biomedical applications of exosomes (2020), PubMed Central</a></li>
<li><a href="https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2025.1569889/full" rel="nofollow noopener noreferrer" target="_blank">Frontiersin (frontiersin.org)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/27318094/" rel="nofollow noopener noreferrer" target="_blank">Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer (2016), PubMed</a></li>
<li><a href="https://pubs.acs.org/" rel="nofollow noopener noreferrer" target="_blank">Pubs (pubs.acs.org)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/21897638/" rel="nofollow noopener noreferrer" target="_blank">Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed</a></li>
<li><a href="https://www.nature.com/articles/s41598-017-10872-3" rel="nofollow noopener noreferrer" target="_blank">Nature (nature.com)</a></li>
<li><a href="https://journals.sagepub.com/doi/10.1177/2515690X211011064" rel="nofollow noopener noreferrer" target="_blank">SAGE Journals</a></li>
<li><a href="https://www.sciencedirect.com/journal/journal-of-pharmaceutical-sciences" rel="nofollow noopener noreferrer" target="_blank">Sciencedirect (sciencedirect.com)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/33402266/" rel="nofollow noopener noreferrer" target="_blank">Nanoparticles of biotite mica as KrishnaVajraAbhraka Bhasma: synthesis and characterization (2021), PubMed</a></li>
<li><a href="https://globalresearchonline.net/journalcontents/v23-1/04.pdf" rel="nofollow noopener noreferrer" target="_blank">Globalresearchonline (globalresearchonline.net)</a></li>
<li><a href="https://link.springer.com/journal/12011" rel="nofollow noopener noreferrer" target="_blank">Link (link.springer.com)</a></li>
<li><a href="https://library.ncl.res.in/content/preparation-and-characterization-copper-based-indian-traditional-drug-tamra-bhasma-0" rel="nofollow noopener noreferrer" target="_blank">Library (library.ncl.res.in)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6598801/" rel="nofollow noopener noreferrer" target="_blank">Study on physical properties of Ayurvedic nanocrystalline Tamra Bhasma by employing modern scientific tools (2019), PubMed Central</a></li>
<li><a href="https://www.dovepress.com/international-journal-of-nanomedicine-journal" rel="nofollow noopener noreferrer" target="_blank">Dovepress (dovepress.com)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9978626/" rel="nofollow noopener noreferrer" target="_blank">Structural investigation of Ayurveda Lauha (Iron) Bhasma (2023), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC539316/" rel="nofollow noopener noreferrer" target="_blank">The blood-brain barrier: bottleneck in brain drug development (2005), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9032478/" rel="nofollow noopener noreferrer" target="_blank">Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology (2022), PubMed Central</a></li>
<li><a href="https://www.sciencedirect.com/journal/nanomedicine-nanotechnology-biology-and-medicine" rel="nofollow noopener noreferrer" target="_blank">Sciencedirect (sciencedirect.com)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6060866/" rel="nofollow noopener noreferrer" target="_blank">Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation (2017), PubMed Central</a></li>
<li><a href="https://jamanetwork.com/journals/jama/fullarticle/182460" rel="nofollow noopener noreferrer" target="_blank">Jamanetwork (jamanetwork.com)</a></li>
<li><a href="https://journals.plos.org/plosone/" rel="nofollow noopener noreferrer" target="_blank">Journals (journals.plos.org)</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/exosome-delivery-bhasma-nanoparticles-ayurveda-2026/feed/</wfw:commentRss>
			<slash:comments>30</slash:comments>
		
		
			</item>
		<item>
		<title>Nanotechnology Carriers for Ayurvedic Bhasma: How Ancient Mineral Medicines Achieve Nano-Scale</title>
		<link>https://www.ayurvedhealing.com/nanotechnology-carriers-ayurvedic-bhasma-nano-scale/</link>
					<comments>https://www.ayurvedhealing.com/nanotechnology-carriers-ayurvedic-bhasma-nano-scale/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Sun, 07 Jun 2026 09:00:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Bhasma]]></category>
		<category><![CDATA[bioavailability]]></category>
		<category><![CDATA[Mineral Medicines]]></category>
		<category><![CDATA[Nano-Particles]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Rasa Shastra]]></category>
		<category><![CDATA[research]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=2534</guid>

					<description><![CDATA[Modern microscopy has confirmed an important but easily overstated point about Ayurvedic bhasma: some preparations contain nanometre-scale crystallites, while the powder actually swallowed may contain much larger agglomerates. In a 2011 study of two Swarna Bhasma batches, X-ray diffraction estimated gold crystallites at 28–35 nm, but particle-size measurements found mean diameters in the hundreds of [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>Modern microscopy has confirmed an important but easily overstated point about Ayurvedic bhasma: some preparations contain nanometre-scale crystallites, while the powder actually swallowed may contain much larger agglomerates. In a 2011 study of two Swarna Bhasma batches, X-ray diffraction estimated gold crystallites at 28–35 nm, but particle-size measurements found mean diameters in the hundreds of nanometres. A 2017 study found crystallites of about 60 nm assembled into irregular aggregates with a mean hydrodynamic diameter of about 4.7 µm. These findings support materials-science study, but they do not prove that every bhasma is a uniform nanoparticle medicine or that nanoscale size establishes clinical efficacy.</p>
<h2>What Is Bhasma? The Classical Pharmaceutical Framework</h2>
<p>Bhasma is a fine calcined preparation made from specified metals, minerals, shells or other substances through formula-specific procedures described in Rasa Shastra literature and official Ayurvedic formularies. There is no universal recipe; the sequence, liquids, auxiliary substances, heat pattern and endpoint tests depend on the material and cited method.</p>
<ol>
<li><strong>Shodhana:</strong> preliminary processing that may involve heating and quenching, boiling, washing, grinding or treatment with prescribed liquids. Calling it removal of all &#8220;toxins&#8221; is too broad; it is material-specific purification and pharmaceutical pretreatment.</li>
<li><strong>Bhavana:</strong> wet grinding or levigation with a specified juice, decoction or other liquid. It mixes ingredients, reduces coarse particles and prepares the mass for further processing.</li>
<li><strong>Marana and Putapaka:</strong> repeated calcination according to the chosen method, often after pellets are enclosed in an earthen <em>sharava-samputa</em>. Modern studies may use a muffle furnace to reproduce a temperature profile. Depending on ingredients and atmosphere, the product may contain elemental metal, oxides, sulfides or mixed phases; the process is not uniformly a reduction reaction.</li>
<li><strong>Amritikarana, where prescribed:</strong> some Tamra or Lauha methods include an additional finishing process. It is not mandatory for every bhasma, and evidence does not support calling it a universal organic coating or proven tissue-targeting step.</li>
</ol>
<p>Classical endpoint examinations include <em>nishchandratva</em> (absence of visible metallic lustre), <em>rekhapurnatva</em> (fineness sufficient to enter finger lines), <em>varitaratva</em> (floating on still water in the prescribed test) and, where relevant, <em>apunarbhava</em>, which examines resistance to reversion toward the original metal. These process checks do not replace modern identity, composition, contamination, particle-distribution and toxicology testing.</p>
<h2>What Microscopy and Diffraction Actually Show</h2>
<p>Published measurements differ because studies examine different products and techniques. XRD crystallite size, TEM primary-particle size, SEM aggregate size and DLS hydrodynamic diameter are not equivalent. A powder can contain nanoscale crystallites while behaving as micron-scale aggregates in liquid.</p>
<table>
<thead>
<tr>
<th>Preparation</th>
<th>Verified finding</th>
<th>Qualification</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swarna Bhasma</td>
<td>Gold crystallites of 28–35 nm in two batches; measured particle diameters were much larger.</td>
<td>In-vitro compatibility does not establish efficacy.</td>
</tr>
<tr>
<td>Swarna Bhasma</td>
<td>A separate report described globular gold-containing particles averaging about 56–57 nm.</td>
<td>Not generalizable to all products.</td>
</tr>
<tr>
<td>Incinerated gold</td>
<td>About 60 nm crystallites formed aggregates averaging about 4.7 µm by DLS.</td>
<td>Cell-culture, preparation-specific evidence.</td>
</tr>
<tr>
<td>Laboratory Swarna Bhasma</td>
<td>FE-TEM reported highly crystalline gold structures containing roughly 5–20 nm particles.</td>
<td>Other studies report micron-scale powder particles.</td>
</tr>
<tr>
<td>Rajata Bhasma</td>
<td>One sample contained crystalline silver in aggregates around 170–210 nm.</td>
<td>Does not support a universal 2–3 nm value.</td>
</tr>
<tr>
<td>Tamra Bhasma</td>
<td>One standardized preparation was mainly cupric sulfide, with 10% below 2 µm.</td>
<td>Chemistry depended on that method.</td>
</tr>
</tbody>
</table>
<p>The defensible conclusion is that bhasma processing can produce complex micro- and nanostructured materials. It is inaccurate to assign one fixed particle size to each named bhasma. Batch variation is a major research and quality-control issue.</p>
<h2>Particle Size, Absorption and Bioavailability</h2>
<p>Smaller particles can have greater surface area, but absorption depends on aggregation, dissolution, chemical species, protein binding, surface charge, dose, food, vehicle and intestinal physiology. General nanoparticle transport mechanisms cannot be automatically assigned to a bhasma without product-specific experiments.</p>
<p>A small 2018 human pilot study measured trace gold in blood after single sublingual or oral Swarna Bhasma doses and reported different concentration-time patterns with different routes and accompanying media. It did not establish long-term pharmacokinetics, tissue distribution, clinical benefit or safety in disease. In a 2017 cell-culture study, smaller incinerated-gold particles appeared to enter cells through clathrin-dependent endocytosis and larger aggregates through macropinocytosis; oral intestinal passage and organism-level effects remained unresolved.</p>
<p>Lauha Bhasma is traditionally used in iron-containing Ayurvedic formulations, and modern work has characterized iron-oxide phases, but comparative clinical bioavailability and gastrointestinal tolerability require proper human trials.</p>
<h2>Herbal Processing and Surface Chemistry</h2>
<p>Plant juices, decoctions, oils, milk products and other media can participate in grinding, complexation, oxidation, sulfide formation and transfer of trace constituents. Analytical studies have detected carbon and multiple elements in some samples. This supports research on process-derived surface chemistry.</p>
<p>Terms such as &#8220;functionalization,&#8221; &#8220;zeta-potential control&#8221; and &#8220;organ targeting&#8221; should be used only when measured for the exact preparation. No reliable human evidence shows that a processing liquid directs bhasma particles selectively to the heart, kidney, brain or another organ. Classical indications and modern nanoparticle-targeting mechanisms are different categories of evidence.</p>
<h2>Specific Preparations: Current Evidence</h2>
<p>Each preparation must be judged as a distinct pharmaceutical material. Traditional indications can guide research, but they do not substitute for verified trials, standardized composition or contemporary diagnosis.</p>
<h3>Swarna Bhasma</h3>
<p>Swarna Bhasma is a calcined gold preparation used in later Rasa Shastra and Ayurvedic pharmaceutical practice. The 2011 in-vitro study found negligible hemolysis, aggregation, platelet activation and cytotoxicity for its tested batches; the 2017 study found no toxicity in two cultured human cell lines under its conditions. These results are assay- and product-specific.</p>
<p>A randomized study of Swarna Bhasma, honey and ghee in healthy infants reported no significant between-group advantage in IgG over honey and ghee alone during the study period. It is not evidence that Swarna preparations function as vaccines or prevent infection. Pediatric use requires specialist oversight and reliable product quality.</p>
<h3>Lauha Bhasma</h3>
<p>Lauha Bhasma is an iron-based preparation produced by methods that may include shodhana, Triphala processing, calcination and amritikarana. Structural studies describe iron-oxide phases rather than one universally fixed compound. A 2016 rat study found no major toxicity at therapeutic-equivalent and five-times levels, but biochemical and histopathological alterations appeared at the highest repeated dose. Animal toxicology neither determines an individual dose nor proves superiority to standard oral iron.</p>
<h3>Pravala Pishti</h3>
<p>Pravala Pishti is a cold-processed coral preparation, not a bhasma produced by repeated incineration. It is made through fine grinding and levigation according to the selected formulary. It should not replace clinically indicated calcium or osteoporosis treatment.</p>
<h2>The Safety Question</h2>
<p>Safety cannot be inferred from the words &#8220;classical,&#8221; &#8220;purified,&#8221; &#8220;nano&#8221; or &#8220;GMP.&#8221; Case reports and surveys have documented lead, mercury or arsenic exposure from some Ayurvedic products, including severe liver injury and systemic toxicity. Conversely, controlled animal studies of particular, characterized bhasmas sometimes report acceptable findings at specified doses and harm at higher doses. Both realities must be acknowledged.</p>
<p>Traditional tests help monitor manufacture, while modern evaluation should include authenticated raw materials, validated process records, chemical speciation, assay of intended ingredients, limits for unintended contaminants, microbial quality and batch-specific certificates of analysis. India&#8217;s Drugs Rules place Ayurvedic, Siddha and Unani manufacturing under Schedule T GMP requirements intended to ensure authentic raw materials, prescribed processes, quality control and acceptable finished-product quality. GMP is important, but it does not guarantee clinical efficacy or zero risk.</p>
<p><strong>Disclaimer:</strong> Never self-prescribe a bhasma or use an unlabelled metallic preparation. Use only a legally manufactured, batch-tested product prescribed by a qualified Ayurvedic physician experienced in Rasa Shastra, and tell your healthcare provider about every medicine and supplement you take. Extra caution and medical review are essential in pregnancy, childhood, kidney or liver disease, anemia of uncertain cause, and when medicines may affect renal, hepatic or blood function. Suspected adverse effects require prompt medical assessment and, when appropriate, blood metal testing.</p>
<h2>Where Research Should Go Next</h2>
<p>Research should establish reproducible manufacturing protocols, distinguish primary particles from aggregates, identify chemical species and surface constituents, measure dissolution and bioaccessibility, and compare batches from multiple manufacturers. Pharmacokinetic studies must track absorption, distribution and elimination rather than relying on one early blood measurement.</p>
<p>Clinical studies should use authenticated products, adequate controls, prespecified outcomes, transparent adverse-event reporting and independent replication. Until then, microscopy shows that classical processing can create complex materials; it does not prove rejuvenation, cognitive enhancement, organ targeting or superior bioavailability. Rasa Shastra is represented more accurately when analytical findings, classical doctrine and clinical claims remain clearly separated.</p>
<h2>References</h2>
<ol>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/21897638/" rel="nofollow noopener noreferrer" target="_blank">Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed</a></li>
<li><a href="https://doi.org/10.1007/BF03215588" rel="nofollow noopener noreferrer" target="_blank">Nanogoldpharmaceutics (2007)</a></li>
<li><a href="https://doi.org/10.1038/s41598-017-10872-3" rel="nofollow noopener noreferrer" target="_blank">Comparative study on cellular entry of incinerated ancient gold particles (Swarna Bhasma) and chemically synthesized gold particles (2017)</a></li>
<li><a href="https://doi.org/10.1016/j.jaim.2021.06.017" rel="nofollow noopener noreferrer" target="_blank">Nanostructured gold in ancient Ayurvedic calcined drug &#8216;swarnabhasma&#8217; (2021)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/32238767/" rel="nofollow noopener noreferrer" target="_blank">Characterization of Rajath Bhasma and Evaluation of Its Toxicity in Zebrafish Embryos and Its Antimicrobial Activity (2020), PubMed</a></li>
<li><a href="https://doi.org/10.4103/0974-8520.110528" rel="nofollow noopener noreferrer" target="_blank">Standard manufacturing procedure of Tamra Bhasma (2012)</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/30459077/" rel="nofollow noopener noreferrer" target="_blank">Assessment of bioavailability of gold bhasma in human participants &#8211; A pilot study (2018), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8078605/" rel="nofollow noopener noreferrer" target="_blank">Immunomodulatory activity of Swarna Prashana (oral administration of gold as electuary) in infants &#8211; A randomized controlled clinical trial (2019), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/27143800/" rel="nofollow noopener noreferrer" target="_blank">Toxicity study of Lauha Bhasma (calcined iron) in albino rats (2016), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6040517/" rel="nofollow noopener noreferrer" target="_blank">Ayurveda metallic-mineral &#8216;Bhasma&#8217;-associated severe liver injury (2018), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6060866/" rel="nofollow noopener noreferrer" target="_blank">Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation (2017), PubMed Central</a></li>
<li><a href="https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2022/drug_rules/Drugs%20Rules%201945_2024%2009.pdf" rel="nofollow noopener noreferrer" target="_blank">CDSCO (India)</a></li>
</ol>
<p><em>Nothing in this article diagnoses or treats a medical condition. Use it as educational information and consult a qualified Ayurvedic practitioner or physician before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant, managing a condition, or taking medication.</em></p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/nanotechnology-carriers-ayurvedic-bhasma-nano-scale/feed/</wfw:commentRss>
			<slash:comments>200</slash:comments>
		
		
			</item>
		<item>
		<title>Heavy Metals in Ayurvedic Products: Testing Standards and What Consumers Should Know</title>
		<link>https://www.ayurvedhealing.com/heavy-metals-ayurvedic-products-testing-standards/</link>
					<comments>https://www.ayurvedhealing.com/heavy-metals-ayurvedic-products-testing-standards/#comments</comments>
		
		<dc:creator><![CDATA[Dr. Meera Iyer]]></dc:creator>
		<pubDate>Wed, 08 Apr 2026 09:00:00 +0000</pubDate>
				<category><![CDATA[Research & Science]]></category>
		<category><![CDATA[Consumer Safety]]></category>
		<category><![CDATA[Heavy Metals]]></category>
		<category><![CDATA[Product Safety]]></category>
		<category><![CDATA[Quality Control]]></category>
		<category><![CDATA[Rasa Shastra]]></category>
		<category><![CDATA[Testing Standards]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/?p=1856</guid>

					<description><![CDATA[A 2008 analysis published in JAMA examined 193 Ayurvedic medicines purchased through the internet from manufacturers in the United States and India. Detectable lead, mercury, or arsenic was found in 20.7% of the products. Every metal-containing product exceeded at least one of the daily-intake standards used by the investigators, and several Indian-manufactured rasa shastra products [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>A 2008 analysis published in <em>JAMA</em> examined 193 Ayurvedic medicines purchased through the internet from manufacturers in the United States and India. Detectable lead, mercury, or arsenic was found in 20.7% of the products. Every metal-containing product exceeded at least one of the daily-intake standards used by the investigators, and several Indian-manufactured <em>rasa shastra</em> products could have supplied lead or mercury at hundreds to thousands of times the cited limits when taken according to their labels. These findings apply to the sampled products rather than to Ayurveda as a whole, but they establish a practical need for ingredient transparency, reliable manufacturing, and batch-specific contaminant testing.</p>
<p>A separate investigation involving users of Ayurvedic products in an Iowa community found that 46 of 115 participants had blood lead concentrations of at least 10 micrograms per decilitre. That value was the investigation’s case threshold, not the current CDC reference value. The CDC now uses 3.5 micrograms per decilitre to identify children with blood lead levels higher than most children’s levels, and it states that this reference value is not a toxicity threshold. No safe blood lead level has been identified for children.</p>
<h2>The Two Pathways by Which Metals Enter Ayurvedic Products</h2>
<p>Metals may enter an Ayurvedic medicine unintentionally as contaminants or may be deliberately included as named ingredients in a classical herbo-mineral formulation. These situations require different forms of assessment, but neither should be judged from packaging claims alone.</p>
<h3>Unintentional Environmental or Manufacturing Contamination</h3>
<p>Medicinal plants can acquire arsenic, cadmium, lead, mercury, and other elements from soil, irrigation water, atmospheric deposition, fertilisers, pesticides, storage containers, grinding equipment, or cross-contamination during manufacture. The World Health Organization’s quality-control manual identifies environmental pollution and agricultural practices as possible sources of arsenic and heavy metals in medicinal plant materials. Similar contamination can affect botanical products from any medical tradition.</p>
<p>A 2018 public-health investigation analysed 252 Ayurvedic samples obtained during the investigation of a lead-poisoning cluster. Lead was detected in 65% of those samples, mercury in 38%, and arsenic in 32%. Because the samples were collected in a cluster investigation rather than through random market sampling, those percentages should not be treated as prevalence estimates for all Ayurvedic medicines. They do demonstrate that contaminated and intentionally metal-containing products can occur together within a supply chain.</p>
<h3>Intentional Inclusion in Rasa Shastra Formulations</h3>
<p><em>Rasa shastra</em> is the Ayurvedic pharmaceutical discipline in which specified herbs may be combined with processed metals, minerals, salts, or gems. Preparations known as <em>bhasmas</em> are produced through procedures that may include <em>shodhana</em> or preparatory processing, wet trituration with prescribed media known as <em>bhavana</em>, and controlled heating or calcination known as <em>marana</em>. The ingredients and processing sequence differ according to the substance and formula; there is no single cycle count, temperature schedule, or processing medium applicable to every bhasma.</p>
<p>Classical and contemporary formulations may include processed gold (<em>Swarna</em> or <em>Suvarna Bhasma</em>), silver (<em>Rajata Bhasma</em>), iron (<em>Lauha Bhasma</em>), copper (<em>Tamra Bhasma</em>), tin (<em>Vanga Bhasma</em>), lead (<em>Naga Bhasma</em>), mica (<em>Abhraka Bhasma</em>), mercury-containing ingredients such as <em>Parada</em> or <em>Hingula</em>, and arsenic-containing substances such as <em>Hartala</em> and <em>Manahshila</em>. These are not interchangeable with ordinary herbal powders and should not be used without appropriate professional supervision and dependable pharmaceutical quality control.</p>
<h2>What Product Surveys Have Established</h2>
<p>The 2008 internet-market study distinguished products marketed as <em>rasa shastra</em> medicines from products described as non-rasa-shastra medicines. Detectable lead, mercury, or arsenic occurred in 40.6% of the rasa-shastra products and 17.1% of the others. The rasa-shastra products were therefore about 2.4 times, rather than six times, as likely to contain one or more of the measured elements.</p>
<p>The presence of an element does not by itself establish its source, chemical form, absorption, or clinical effect. Nevertheless, total concentration and the labelled daily dose are essential safety measurements. A product that supplies an excessive daily quantity of lead, mercury, arsenic, or cadmium remains a concern regardless of whether the element entered through soil, manufacturing equipment, substitution, cross-contamination, or deliberate formulation.</p>
<p>Documented poisonings have been associated with Ayurvedic products containing excessive concentrations of toxic elements. Public-health agencies in the United States and Australia have continued to issue warnings about specific imported or unapproved products containing lead, mercury, arsenic, and, in some cases, other undeclared toxic substances. Consumers should act on a warning for the named product and batch rather than assuming that country of origin, price, a “natural” claim, or traditional terminology guarantees quality.</p>
<h2>How Regulatory Frameworks Differ</h2>
<p>Ayurvedic products may be regulated as medicines, traditional herbal medicines, dietary supplements, complementary medicines, or imported unapproved products, depending on the jurisdiction and the claims made for them. The practical question is not merely whether a country has a numerical metal limit, but which legal category applies to the specific product and what evidence was reviewed before sale.</p>
<table border="1" cellpadding="8" cellspacing="0" style="width:100%;border-collapse:collapse;">
<thead>
<tr style="background-color:#f5f0e8;">
<th>Jurisdiction</th>
<th>Relevant Framework</th>
<th>What a Consumer Can Check</th>
<th>Important Limitation</th>
</tr>
</thead>
<tbody>
<tr>
<td>United States</td>
<td>Most orally consumed Ayurvedic supplements are sold under the dietary-supplement framework and must comply with applicable FDA labelling and 21 CFR Part 111 manufacturing requirements.</td>
<td>Full Supplement Facts panel, manufacturer identity, lot number, product-level USP or NSF certification, and a batch-specific laboratory report.</td>
<td>FDA generally does not approve dietary supplements before marketing. Facility registration or the phrase “FDA registered” is not product approval or certification.</td>
</tr>
<tr>
<td>India</td>
<td>Ayurvedic, Siddha, and Unani medicines are covered by Chapter IVA of the Drugs and Cosmetics Act and the applicable Drugs Rules. Schedule T specifies GMP requirements, while Rule 161 addresses ingredient labelling.</td>
<td>Manufacturer, manufacturing licence details, batch and expiry information, complete ingredients, dosage, required warnings, and a batch Certificate of Analysis.</td>
<td>A GMP licence concerns the manufacturing system; it does not by itself disclose the measured metal content of the purchased batch.</td>
</tr>
<tr>
<td>European Union</td>
<td>Herbal medicinal products may require marketing authorisation or traditional-use registration. EMA quality guidance addresses identity, contaminants, microbiology, pesticides, mycotoxins, and toxic metals.</td>
<td>National registration or authorisation details, approved leaflet, labelled composition, and manufacturer.</td>
<td>A food supplement is not evaluated through the same pathway as a registered herbal medicinal product.</td>
</tr>
<tr>
<td>United Kingdom</td>
<td>Eligible traditional herbal medicinal products may be registered through the MHRA Traditional Herbal Registration scheme.</td>
<td>A genuine THR number or authorised THR certification mark and the accompanying patient information.</td>
<td>THR confirms required standards for quality, safety, and traditional use; it does not mean that effectiveness was assessed to the standard required for a conventional marketing authorisation.</td>
</tr>
<tr>
<td>Australia</td>
<td>Complementary medicines supplied legally are generally entered in the Australian Register of Therapeutic Goods as listed, assessed-listed, or registered medicines.</td>
<td>An AUST L, AUST L(A), or AUST R number on the label and a corresponding ARTG entry.</td>
<td>Unregistered products obtained through overseas websites, personal importation, or informal sellers may fall outside the normal Australian supply controls.</td>
</tr>
</tbody>
</table>
<h2>Why a Single “Permissible ppm” Number Is Inadequate</h2>
<p>Acceptable specifications depend on the product category, element, daily dose, route of administration, intended duration, applicable pharmacopoeia, and national law. Concentration expressed in parts per million or milligrams per kilogram must be considered together with the quantity consumed each day. Two products with the same concentration can produce different daily exposure when their recommended doses differ greatly.</p>
<p>The WHO manual on medicinal plant materials proposed maximum amounts of 10 milligrams per kilogram for lead and 0.3 milligrams per kilogram for cadmium in dried plant materials. It did not establish a universal four-element limit of 10 ppm lead, 1 ppm mercury, 3 ppm arsenic, and 0.3 ppm cadmium for every herbal medicine, dietary supplement, bhasma, and finished dosage form. A laboratory report should identify the specification used rather than merely stating “within WHO limits.”</p>
<p>Voluntary product-level programmes can provide additional assurance. The USP Verified programme evaluates identity, labelled strength or amount, contaminants such as heavy metals, manufacturing practices, and product performance. NSF/ANSI 173 certification likewise includes label-claim and contaminant requirements. These marks should be verified in the certifier’s current online directory because a facility-level GMP certificate is different from certification of a particular finished product.</p>
<h2>Reading the Ingredient List for Metal and Mineral Components</h2>
<p>Dosage form alone does not determine whether a product is herbal-only. A <em>churna</em>, <em>vati</em>, <em>gutika</em>, <em>avaleha</em>, <em>asava</em>, <em>arishta</em>, oil, capsule, or tablet may be herbal or may form part of a multi-ingredient preparation. The complete formula and source text or manufacturer’s specification must be examined.</p>
<p>Terms that warrant closer review include:</p>
<ul>
<li><em>Bhasma</em>, indicating a specifically processed ash or calcined material.</li>
<li><em>Parada</em>, <em>Hingula</em>, <em>Rasa Sindura</em>, or related mercury-containing ingredients.</li>
<li><em>Naga</em>, <em>Vanga</em>, <em>Tamra</em>, <em>Lauha</em>, <em>Mandura</em>, <em>Yashada</em>, <em>Rajata</em>, or <em>Swarna/Suvarna</em> when used as processed metal ingredients.</li>
<li><em>Hartala</em>, <em>Manahshila</em>, or <em>Gauripashana</em>, which are arsenic-containing mineral substances.</li>
<li><em>Abhraka</em>, <em>Makshika</em>, and other mineral ingredients requiring substance-specific processing and testing.</li>
</ul>
<p>A single-herb powder or extract labelled only with a verified botanical species, plant part, and excipients has no declared herbo-metallic ingredient, but it can still contain environmental or manufacturing contaminants. Conversely, familiar formula names should not be classified as safe or hazardous solely from the name because compositions can differ among classical references, proprietary versions, and manufacturers.</p>
<h2>How Bhasma Preparation and Testing Should Be Understood</h2>
<p>Traditional bhasma manufacture is substance-specific. Processes described in rasa-shastra literature may use repeated purification, grinding, levigation with designated liquids, pellet formation, sealing, and controlled heating. Classical finishing examinations such as <em>nischandratva</em>, <em>rekhapurnatva</em>, <em>varitara</em>, <em>apunarbhava</em>, and <em>niruttha</em> assess characteristics such as absence of metallic lustre, fineness, floating behaviour, and resistance to reversion under specified conditions. They form part of traditional pharmaceutical assessment but do not replace contemporary chemical, microbiological, and toxicological controls.</p>
<p>Instrumental methods answer different questions. Inductively coupled plasma mass spectrometry or optical-emission spectrometry can quantify total elemental content. X-ray diffraction can help identify crystalline phases, while electron microscopy can describe particle size and morphology. Additional methods may be needed to examine chemical speciation, dissolution, bioaccessibility, organic contaminants, microbes, pesticides, and batch-to-batch consistency. A result from one technique should not be presented as proof that a product is nontoxic.</p>
<p>One published characterization reported globular gold-containing particles averaging approximately 56–57 nanometres in a particular Swarna Bhasma sample. Other bhasma analyses have reported different particle sizes, aggregates, and chemical phases. The measurement therefore describes the tested material, not every Swarna Bhasma or all bhasmas. The presence of nanoscale particles is an analytical characteristic rather than an independent guarantee of purity, therapeutic benefit, or safety.</p>
<h2>A Practical Consumer Safety Checklist</h2>
<p>A responsible purchase should be traceable from the labelled ingredients and lot number to the manufacturer and the results for that production batch. The following checks are more useful than broad claims such as “ancient,” “natural,” “organic,” “laboratory tested,” or “made in an FDA-registered facility.”</p>
<ol>
<li><strong>Read every ingredient:</strong> Confirm the botanical name, plant part, extract ratio where relevant, excipients, and every metal or mineral ingredient. Do not rely only on the front-label product name.</li>
<li><strong>Match the product to its regulatory category:</strong> Check the manufacturing licence and required particulars in India, a THR registration in the United Kingdom, an ARTG number in Australia, or applicable dietary-supplement labelling in the United States.</li>
<li><strong>Request a batch-specific Certificate of Analysis:</strong> The report should match the lot number and identify the laboratory, test date, method, reporting units, detection or quantification limits, numerical results, and specifications for lead, cadmium, arsenic, and mercury.</li>
<li><strong>Prefer an accredited laboratory:</strong> Look for testing performed within the laboratory’s accredited scope, commonly under ISO/IEC 17025. A manufacturer-created summary containing only the word “pass” provides less information than the signed analytical report.</li>
<li><strong>Distinguish product certification from factory certification:</strong> GMP is important, but it does not mean that every finished batch has independently passed every contaminant test. Confirm whether a USP or NSF mark applies to the exact product.</li>
<li><strong>Use greater caution with herbo-mineral products:</strong> Do not self-prescribe products containing lead-, mercury-, or arsenic-derived ingredients. Obtain them only under the guidance of a qualified Ayurvedic practitioner who can assess the indication, dose, duration, contraindications, and source.</li>
<li><strong>Protect children and pregnancy:</strong> Children, fetuses, and pregnant people require particular protection from lead exposure. Discuss all Ayurvedic medicines and supplements with the treating healthcare professional before use.</li>
<li><strong>Keep traceability records:</strong> Retain the container, invoice, batch number, expiry date, photographs of the label, and remaining tablets or powder if an adverse event or exposure concern arises.</li>
<li><strong>Check regulator alerts:</strong> Search the relevant national regulator’s current safety notices before purchasing an imported product, especially when the seller provides no verifiable manufacturer or batch information.</li>
</ol>
<h2>Quality Control for Herbal-Only Products</h2>
<p>Absence of an intentional metal ingredient is only one aspect of botanical quality. Correct identity requires the proper genus, species, plant part, and, where relevant, macroscopic, microscopic, chemical, or chromatographic characteristics. Substitution with a related species, use of the wrong plant part, excessive foreign matter, poor storage, and degradation can change a product even when its metal results are acceptable.</p>
<p>A suitable quality programme may also address pesticides, microbial contamination, aflatoxins or other mycotoxins, residual solvents, foreign matter, and adulterants according to the product and manufacturing process. Consumers should therefore avoid treating a heavy-metal certificate as a complete certificate of safety. It is one important component of identity, purity, strength, and contamination control.</p>
<div style="background-color:#fff8e7;border-left:4px solid #e6ac00;padding:12px 16px;margin:20px 0;"> <strong>Safety Disclaimer:</strong> This article is for educational purposes and does not replace medical diagnosis or treatment. Consult a qualified Ayurvedic practitioner and an appropriate healthcare provider before using any bhasma or herbo-mineral preparation, and before giving an Ayurvedic medicine to a child or using one during pregnancy. Suspected exposure may require blood, urine, or other testing selected according to the element, chemical form, dose, and timing. Contact a healthcare professional or poison-control service promptly after a known high exposure or if abdominal pain, vomiting, weakness, confusion, numbness, tremor, or other neurological symptoms occur. Do not discontinue prescribed medical treatment without professional advice. </div>
<p><strong>Actionable Tip:</strong> Select one Ayurvedic product you currently use and compare its lot number with its Certificate of Analysis. Confirm that the document reports actual numerical results for lead, cadmium, arsenic, and mercury, names the analytical method and laboratory, and states the specification applied. When the manufacturer cannot provide a traceable batch report, the ingredients are incomplete, or the product contains a metal or mineral that was not clearly disclosed at purchase, pause further use and seek advice from a qualified practitioner or healthcare provider.</p>
<h2>References</h2>
<ol>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/18728265/" rel="nofollow noopener noreferrer" target="_blank">Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2755247/" rel="nofollow noopener noreferrer" target="_blank">Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4727589/" rel="nofollow noopener noreferrer" target="_blank">A cluster of lead poisoning among consumers of Ayurvedic medicine (2015), PubMed Central</a></li>
<li><a href="https://www.cdc.gov/lead-prevention/php/news-features/updates-blood-lead-reference-value.html" rel="nofollow noopener noreferrer" target="_blank">CDC</a></li>
<li><a href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7043a4.htm" rel="nofollow noopener noreferrer" target="_blank">CDC</a></li>
<li><a href="https://www.who.int/docs/default-source/medicines/norms-and-standards/guidelines/quality-control/quality-control-methods-for-medicinal-plant-materials.pdf" rel="nofollow noopener noreferrer" target="_blank">World Health Organization</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6060866/" rel="nofollow noopener noreferrer" target="_blank">Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation (2017), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3960793/" rel="nofollow noopener noreferrer" target="_blank">Bhasma : The ancient Indian nanomedicine (2014), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3665084/" rel="nofollow noopener noreferrer" target="_blank">Characterization of Tarakeshwara Rasa: An Ayurvedic herbomineral formulation (2012), PubMed Central</a></li>
<li><a href="https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://www.fda.gov/food/dietary-supplements" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf" rel="nofollow noopener noreferrer" target="_blank">CDSCO (India)</a></li>
<li><a href="https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2022/drug_rules/Drugs%20Rules%201945_2024%2009.pdf" rel="nofollow noopener noreferrer" target="_blank">CDSCO (India)</a></li>
<li><a href="https://www.ema.europa.eu/en/documents/scientific-guideline/final-guideline-quality-herbal-medicinal-productstraditional-herbal-medicinal-products-revision-3_en.pdf" rel="nofollow noopener noreferrer" target="_blank">Ema (ema.europa.eu)</a></li>
<li><a href="https://www.ema.europa.eu/en/human-regulatory-overview/herbal-medicinal-products" rel="nofollow noopener noreferrer" target="_blank">Ema (ema.europa.eu)</a></li>
<li><a href="https://www.gov.uk/guidance/apply-for-a-traditional-herbal-registration-thr" rel="nofollow noopener noreferrer" target="_blank">Gov (gov.uk)</a></li>
<li><a href="https://assets.publishing.service.gov.uk/media/547307ff40f0b6130e000038/con060025.pdf" rel="nofollow noopener noreferrer" target="_blank">Assets (assets.publishing.service.gov.uk)</a></li>
<li><a href="https://www.tga.gov.au/resources/consumer-information-and-resources/medicines-safety-and-general-information-consumers/how-we-regulate-medicines" rel="nofollow noopener noreferrer" target="_blank">Tga (tga.gov.au)</a></li>
<li><a href="https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/imported-ayurvedic-products-found-contain-dangerous-heavy-metals" rel="nofollow noopener noreferrer" target="_blank">Tga (tga.gov.au)</a></li>
<li><a href="https://www.usp.org/verification-services/verified-mark" rel="nofollow noopener noreferrer" target="_blank">Usp (usp.org)</a></li>
<li><a href="https://www.nsf.org/consumer-resources/articles/selecting-dietary-nutritional-supplements" rel="nofollow noopener noreferrer" target="_blank">Nsf (nsf.org)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4492018/" rel="nofollow noopener noreferrer" target="_blank">A critical appraisal on Swarnaprashana in children (2014), PubMed Central</a></li>
<li><a href="https://iris.who.int/bitstream/handle/10665/44479/9789241500739_eng.pdf?sequence=1" rel="nofollow noopener noreferrer" target="_blank">World Health Organization</a></li>
<li><a href="https://www.cdc.gov/lead-prevention/hcp/clinical-guidance/index.html" rel="nofollow noopener noreferrer" target="_blank">CDC</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/heavy-metals-ayurvedic-products-testing-standards/feed/</wfw:commentRss>
			<slash:comments>59</slash:comments>
		
		
			</item>
		<item>
		<title>Copper Water, Clay Pots, and Gold-Infused Ghee: Ayurvedic Metal Therapy</title>
		<link>https://www.ayurvedhealing.com/copper-water-clay-pots-and-gold-infused-ghee-ayurvedic/</link>
					<comments>https://www.ayurvedhealing.com/copper-water-clay-pots-and-gold-infused-ghee-ayurvedic/#comments</comments>
		
		<dc:creator><![CDATA[Rohan Kapoor]]></dc:creator>
		<pubDate>Sat, 21 Feb 2026 16:45:18 +0000</pubDate>
				<category><![CDATA[Herbal Remedies]]></category>
		<category><![CDATA[Ayurvedic kitchen]]></category>
		<category><![CDATA[clay pot cooking]]></category>
		<category><![CDATA[copper water]]></category>
		<category><![CDATA[gold therapy]]></category>
		<category><![CDATA[metal therapy]]></category>
		<category><![CDATA[Rasa Shastra]]></category>
		<category><![CDATA[Swarna Bhasma]]></category>
		<category><![CDATA[Tamra Jal]]></category>
		<category><![CDATA[traditional remedies]]></category>
		<guid isPermaLink="false">https://www.ayurvedhealing.com/copper-water-clay-pots-gold-ghee-ayurvedic-metal-therapy/</guid>

					<description><![CDATA[My Grandmother's Copper Vessel and the Science I Found 30 Years Later Every morning of my childhood, my grandmother would fill a copper vessel with water...]]></description>
										<content:encoded><![CDATA[<h2>My Grandmother&#8217;s Copper Vessel and the Science I Found 30 Years Later</h2>
<p>Every morning of my childhood, my grandmother would fill a copper vessel with water before going to bed and hand me a glass of it the next morning. “Tamra jal,” she called it: copper water. I drank it without question, the way children accept family rituals as facts of the universe. Years later, while studying Ayurvedic food habits, vessel selection, and the pharmaceutics of metals and minerals, I understood that she was not treating copper as magic. She was using a simple household practice with clear boundaries: the right vessel, plain water, a modest quantity, and regular cleaning.</p>
<p>Ayurveda distinguishes sharply between household vessel practices and specialized internal preparations made from metals or minerals. Copper water, clay-pot cooking, silver cups, and cast-iron cooking belong to practical kitchen use. Swarna Bhasma and other bhasma preparations belong to the physician’s domain and require purification, calcination, quality testing, and careful dosing. The value of these traditions lies not in casual metal consumption, but in disciplined use.</p>
<h2>Copper Water (Tamra Jal): The Everyday Practice</h2>
<p>Copper water is the most accessible metal-related practice in many Indian homes. It is best understood as a small daily vessel practice, not as a replacement for mineral supplements, clean drinking-water standards, or medical care.</p>
<h3>The Traditional Method</h3>
<p>My grandmother’s method was simple. She used an unlined copper vessel reserved only for plain water. Every night, she filled it with filtered water, covered it, and left it undisturbed until morning. She drank one small glass, about 150–200 ml, before tea or breakfast. The water had a faint metallic taste, but it was never sour, greenish, cloudy, or stored for days.</p>
<p>Use a food-grade, unlined copper vessel from a reliable maker. Avoid lacquered, copper-plated, brass, or decorative vessels for this practice. Fill it with plain drinking water and let it stand overnight. Do not use copper vessels for milk, curd, citrus juice, tamarind water, vinegar-based drinks, or other acidic liquids. Discard leftover water after the morning use, rinse the vessel, and allow it to dry.</p>
<h3>Why the Practice Makes Sense</h3>
<p>Laboratory testing has found that water deliberately contaminated with diarrhoeal bacteria became free of recoverable bacteria after 16 hours of storage in copper pots at room temperature. The copper level measured in that water was about 177 ± 16 ppb, which is below the World Health Organization guideline value of 2 mg/L for copper in drinking water.</p>
<p>Copper is also an essential trace mineral. The body uses it in enzymes involved in iron metabolism, connective-tissue formation, neurotransmitter synthesis, and antioxidant defense. The adult recommended dietary allowance is 900 micrograms per day. Copper water should still be treated as a small supplementary exposure, not as an all-day drinking habit.</p>
<h3>Practical Tips from Our Kitchen</h3>
<p>My mother, who learned the habit from her mother, kept a few rules that still make sense today. Clean the copper vessel regularly with lemon and salt or tamarind, but rinse it thoroughly so no acidic residue remains. Use it only for plain water. Stop using the vessel if the inside develops heavy green corrosion, a strong metallic smell, or a bitter taste that does not clear after cleaning. People with Wilson disease, known copper metabolism disorders, significant liver disease, or unexplained abdominal symptoms should avoid copper-water routines unless advised by a qualified healthcare provider.</p>
<h2>Clay Pot Cooking (Mritika Patra): The Forgotten Kitchen Essential</h2>
<p>Clay-pot cooking is not metal therapy, but it belongs in the same conversation because Ayurveda pays attention to the vessel, the cooking medium, the heat, and the qualities transferred to food. Before stainless steel and non-stick cookware took over Indian kitchens, my grandmother cooked rice, dal, and slow curries in unglazed clay pots. She simply said the food tasted softer and more grounded.</p>
<h3>Why Clay Matters</h3>
<p>Unglazed clay pots cook gently and retain moisture well when used over low heat. This suits foods such as mung dal, khichdi, rice, vegetable stews, and thin curries that benefit from slow simmering. In Ayurvedic language, this style of cooking supports softness, digestibility, and warmth without the harshness of aggressive high heat.</p>
<p>The safety of the pot matters more than romantic nostalgia. Use only unglazed, lead-free, food-safe clay cookware from a trusted source. Avoid decorative pottery, unknown glazes, bright painted interiors, or antique vessels for cooking. Acidic foods can draw unsafe metals out of poorly made glazed pottery, so untested decorative ceramics should never be used for daily food preparation.</p>
<h3>Choosing and Seasoning Clay Pots</h3>
<p>To prepare a new clay pot, soak it in water for several hours, dry it, rub the inside lightly with cooking oil, and heat it slowly over a low flame. Repeat gentle heating before cooking a full meal. Clay dislikes sudden temperature changes, so never place a cold pot directly on a high flame, never pour cold water into a hot pot, and never move it from the stove to a wet stone counter.</p>
<h3>My Favorite Clay Pot Recipe: Grandmother’s Mung Dal</h3>
<p>This is the simple dal my grandmother made every week. The clay pot gives it a soft texture and earthy aroma that is difficult to reproduce in a thin metal pan.</p>
<p><strong>Ingredients:</strong></p>
<ul>
<li>1 cup split mung dal, washed and soaked for 30 minutes</li>
<li>3 cups water</li>
<li>1/2 teaspoon turmeric powder</li>
<li>1 teaspoon ghee</li>
<li>1/2 teaspoon cumin seeds</li>
<li>1 small piece of fresh ginger, grated</li>
<li>Pinch of asafoetida</li>
<li>Salt to taste</li>
<li>Fresh coriander leaves for garnish</li>
</ul>
<p><strong>Method:</strong> Add the dal, water, and turmeric to the clay pot. Bring it to a gentle simmer over medium-low heat. Cook for 25–30 minutes, or until the dal is completely soft. In a small pan, warm the ghee, add cumin seeds, ginger, and asafoetida, then pour the tempering over the dal. Garnish with coriander and serve warm.</p>
<h2>Gold Preparations (Swarna): The Specialized Practice</h2>
<p>Gold occupies a respected place in Ayurvedic pharmaceutics, but it should not be treated as a casual kitchen supplement. Classical and later Rasashastra traditions describe the use of metals only after purification and processing. Swarna Bhasma is not raw gold dust; it is a processed preparation made through repeated purification, trituration, and calcination steps.</p>
<h3>The Rasa Shastra Tradition</h3>
<p>In Rasashastra, metals and minerals are transformed through procedures such as shodhana and marana before internal use. These processes are intended to remove unwanted qualities, reduce particle size, and make the material suitable for carefully prescribed therapeutic use. Modern characterization of Swarna Bhasma has found nanoscale gold particles or crystallites in some properly prepared samples, which helps explain why classical processing is treated as essential rather than optional.</p>
<h3>Swarna Prashana: The Children’s Practice</h3>
<p>Swarna Prashana is a traditional pediatric practice associated with the Kashyapa Samhita. It involves administering a minute physician-selected quantity of processed gold preparation with carriers such as honey and ghee. In the classical description, it is connected with medha, agni, bala, and ayushya: intellect, digestion, strength, and longevity.</p>
<p>This practice should not be improvised at home. Children should never be given raw gold powder, scraped jewelry, uncertified bhasma, or internet-purchased preparations without professional assessment. Swarna Prashana is not a substitute for vaccination, pediatric nutrition, diagnosis, or treatment. It belongs under the supervision of a qualified Ayurvedic pediatric practitioner.</p>
<h3>A Gentler Family Ritual: Gold-Contact Water</h3>
<p>Some families keep a simple ritual of boiling water with a clean piece of pure gold and then drinking the warm water after removing the gold. This should be understood as a traditional contact-water ritual, not as a therapeutic dose of gold. Use only plain, clean, high-purity gold without stones, solder, plating, or chemical polish. Do not use jewelry of uncertain composition, and do not treat this as a substitute for Swarna Bhasma or prescribed care.</p>
<h2>Silver Vessels and Cast Iron: Two Useful Notes</h2>
<p>Silver and iron have their own distinct roles in traditional kitchens. Silver is commonly associated with cooling, clean storage, and ritual serving, while iron cookware can contribute measurable dietary iron to food under the right cooking conditions.</p>
<p><strong>Silver (Rajata):</strong> Silver vessels may be used for plain water or occasional serving, especially in households that follow cooling Pitta-oriented routines. Silver ions and silver nanoparticles are known for antimicrobial activity, but silver water should not be used as a treatment for infections, urinary complaints, acidity, or fever. Keep the use modest, clean the vessel properly, and avoid silver products marketed as cure-all tonics.</p>
<p><strong>Iron (Loha):</strong> Cooking in cast iron can increase the iron content of foods, especially moist and acidic preparations cooked for longer periods. This can be useful for families trying to improve dietary iron intake through food habits, but it is not a complete anemia treatment. People with iron-overload disorders such as hemochromatosis should avoid intentionally increasing iron exposure through cookware unless guided by a clinician.</p>
<h2>Safety: The Non-Negotiable Rules</h2>
<p>The difference between a safe Ayurvedic vessel practice and unsafe metal exposure is preparation, dose, quality, indication, and supervision. Household practices should stay simple: plain water in copper or silver, slow cooking in verified food-safe clay, and ordinary cooking in cast iron. Internal bhasma preparations require a qualified practitioner and a trustworthy pharmacy.</p>
<ul>
<li>Never consume raw metal powder, scraped jewelry, homemade bhasma, or unlabelled rasaushadhi.</li>
<li>Buy bhasma preparations only from licensed, quality-controlled Ayurvedic pharmacies that can provide testing for lead, mercury, arsenic, and other contaminants.</li>
<li>Do not use decorative, glazed, painted, or antique pottery for cooking unless it is certified food-safe and lead-safe.</li>
<li>Use copper and silver vessels only for plain water, not acidic liquids, fermented drinks, milk, or long storage.</li>
<li>Pregnant and breastfeeding women, children, older adults, and people with liver disease, kidney disease, Wilson disease, iron-overload disorders, or chronic medication use should consult a qualified practitioner or healthcare provider before using metal or mineral preparations.</li>
</ul>
<p>My grandmother did not speak in the language of trace minerals, copper ions, or nanoscale particles. She spoke in the language of habit: use the right vessel, keep it clean, do not overdo it, and respect what is potent. That is still the best way to understand Ayurvedic metal practices today.</p>
<blockquote>
<p><strong>Disclaimer:</strong> This article describes traditional Ayurvedic vessel practices and specialized metal/mineral preparations for educational purposes. Copper water, clay-pot cooking, silver vessels, and cast-iron cooking can be safe when used appropriately, but bhasma and other internal metal/mineral preparations should be used only under the guidance of a qualified Ayurvedic practitioner or healthcare provider. This content does not replace medical advice, diagnosis, or treatment.</p>
</blockquote>
<p><em>Rohan Kapoor is an Ayurvedic nutrition writer based in Chandigarh. This article is for educational purposes only. Consult a qualified nutritionist, Ayurvedic practitioner, or healthcare provider before making significant dietary changes, especially if you have existing health conditions.</em></p>
<h2>References</h2>
<ol>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/22524115/" rel="nofollow noopener noreferrer" target="_blank">Storing drinking-water in copper pots kills contaminating diarrhoeagenic bacteria (2012), PubMed</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3312355/" rel="nofollow noopener noreferrer" target="_blank">Storing drinking-water in copper pots kills contaminating diarrhoeagenic bacteria (2012), PubMed Central</a></li>
<li><a href="https://cdn.who.int/media/docs/default-source/wash-documents/wash-chemicals/copper.pdf" rel="nofollow noopener noreferrer" target="_blank">Cdn (cdn.who.int)</a></li>
<li><a href="https://ods.od.nih.gov/factsheets/Copper-HealthProfessional/" rel="nofollow noopener noreferrer" target="_blank">NIH Office of Dietary Supplements</a></li>
<li><a href="https://www.fda.gov/food/environmental-contaminants-food/questions-and-answers-lead-glazed-traditional-pottery" rel="nofollow noopener noreferrer" target="_blank">FDA</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3252715/" rel="nofollow noopener noreferrer" target="_blank">Introduction to &#8216;Rasashaastra&#8217; the Iatrochemistry of Ayurveda (2011), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3960793/" rel="nofollow noopener noreferrer" target="_blank">Bhasma : The ancient Indian nanomedicine (2014), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/21897638/" rel="nofollow noopener noreferrer" target="_blank">Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed</a></li>
<li><a href="https://link.springer.com/article/10.1007/BF03215588" rel="nofollow noopener noreferrer" target="_blank">Link (link.springer.com)</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4492018/" rel="nofollow noopener noreferrer" target="_blank">A critical appraisal on Swarnaprashana in children (2014), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7451701/" rel="nofollow noopener noreferrer" target="_blank">Swarna Bindu Prashana-an Ancient Approach to Improve the Infant&#8217;s Immunity (2021), PubMed Central</a></li>
<li><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7127744/" rel="nofollow noopener noreferrer" target="_blank">Silver nanoparticles as an effective disinfectant: A review (2019), PubMed Central</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/3722654/" rel="nofollow noopener noreferrer" target="_blank">Iron content of food cooked in iron utensils (1986), PubMed</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/18728265/" rel="nofollow noopener noreferrer" target="_blank">Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed</a></li>
<li><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5326a3.htm" rel="nofollow noopener noreferrer" target="_blank">CDC</a></li>
<li><a href="https://naturalingredient.org/wp/wp-content/uploads/API-Vol-7.pdf" rel="nofollow noopener noreferrer" target="_blank">Natural Ingredient Resource Center</a></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://www.ayurvedhealing.com/copper-water-clay-pots-and-gold-infused-ghee-ayurvedic/feed/</wfw:commentRss>
			<slash:comments>60</slash:comments>
		
		
			</item>
	</channel>
</rss>
